STOCK TITAN

AtlasClear quarterly loss widens to $1.05M

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

AtlasClear Holdings, Inc. (ATCH) reported revenue of $5.39 million for the three months ended September 30, 2026, versus $4.25 million a year earlier, while net loss widened to $1.05 million from $440,294. Operating expenses were $7.91 million. Net cash used in operating activities was $3.87 million, compared with $2.50 million a year earlier.

As of September 30, 2026, unrestricted cash and cash equivalents were $9.4 million. The company reported significant cash outflows, including a $2.5 million payment in October related to the Ark acquisition; another $2.44 million is expected at closing, and a $2.5 million seller note matures in January 2027. Management said forecast operating cash flows and existing cash balances may not cover all anticipated obligations, but cited accessible capital resources and concluded there is no substantial doubt about the company’s ability to continue as a going concern.

NYSE American suspended trading in ATCH on November 10, 2026, and began delisting proceedings, citing the stock’s low selling price. The company intends to request a review, though it said there can be no assurance the appeal will succeed. Since November 11, 2026, the stock has traded on OTC Pink Limited Market.

1 point · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 3 points

How the balance works

Positive

  • Moderate pointRevenue reached $5.39 million, up from $4.25 million year over year.

Negative

  • Major pointNYSE American suspended ATCH trading, citing low selling price and delisting proceedings.
  • Moderate pointNet loss widened to $1.05 million from $440,294 year over year.
  • Moderate pointOperating cash outflow increased to $3.87 million from $2.50 million.

Filing Explained

Separate from issued shares, the filing lists 18,679,636 convertible securities, 18,979,843 performance-based awards, and 32,441,602 warrants excluded from diluted loss per share.

This unaudited quarterly report shows AtlasClear had 151,838,744 common shares outstanding at September 30, 2026, compared with 150,337,774 at June 30, 2026. During the quarter, it issued 1,400,000 shares to officers under stock-based compensation and 100,970 shares in a non-cash warrant exercise; issuing shares reduces existing holders’ percentage ownership absent offsetting changes.

Separately, the filing lists 18,679,636 convertible securities, 18,979,843 performance-based stock awards, and 32,441,602 warrants as excluded from diluted loss per share. These are distinct from the reported outstanding shares; if they result in additional shares, total share count rises and existing holders’ percentage ownership falls, absent offsetting changes.

Under the Commercial Bancorp purchase agreement, sellers may elect all-cash, all-share, or mixed consideration, with the amount based on adjusted book value, premises value, and a tax benefit. Closing conditions include required regulatory approvals; the filing says the resale registration statement was declared effective on June 17, 2026.

Revenue $5,394,111 Three months ended September 30, 2026; $4,250,590 in the 2025 period
Stock-locate fees $2,997,205 Three months ended September 30, 2026
Net loss $1,052,971 loss Three months ended September 30, 2026; $440,294 loss in the 2025 period
Net cash used in operating activities $3,867,059 Three months ended September 30, 2026; $2,500,236 used in the 2025 period
Cash and cash equivalents $9,431,777 At September 30, 2026; described as unrestricted cash and cash equivalents
Revolving line of credit $10,000,000 No balance outstanding as of September 30, 2026; available for clearing margin deposits
AtlasClearing net capital $15,166,441 At September 30, 2026; $14,916,441 above the minimum required
Common shares outstanding 151,838,744 shares As of November 3, 2026
stock locate fees financial
"Stock locate fees"
Rule 15c3-3 regulatory
"required by Rule 15c3-3 of the Exchange Act to maintain a cash reserve"
uniform net capital rule regulatory
"subject to the uniform net capital rule adopted and administered by the SEC"
Fair Value Option financial
"The Company elected to apply the Fair Value Option (FVO)"
An accounting election that lets a company measure eligible financial assets and liabilities at their current market price, recording gains and losses in the income statement as those prices move. For investors it matters because choosing the fair value option makes reported profits and asset values respond immediately to market swings—like revaluing a house to today’s sale price—so it can increase earnings volatility while giving a more up‑to‑date view of value.
antidilutive financial
"rendering their inclusion antidilutive under the treasury stock method"
Describes a potential common share — such as a convertible bond, convertible preferred, option or warrant — that would, if included in the diluted earnings-per-share calculation, increase (or fail to decrease) reported earnings per share rather than dilute it. Accounting rules require such securities to be excluded from diluted EPS because their assumed conversion would make EPS higher (or make a loss per share smaller), so they are not treated as dilutive when reporting diluted figures.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What drove ATCH’s revenue in the quarter ended September 30, 2026?

Stock-locate fees contributed $2,997,205 of revenue. Commissions were $1,736,434, vetting fees $230,015, clearing fees $101,786, net gain on firm trading accounts $66,825, and other revenue $261,846.

Why was ATCH’s trading suspended, and what happened next?

NYSE American said the common stock was no longer suitable for listing because of its low selling price. ATCH intends to request a review, though the company said there can be no assurance the appeal will succeed. Since November 11, 2026, its common stock has traded on OTC Pink Limited Market.

Does ATCH have unused credit available for clearing requirements?

AtlasClearing has a $10 million revolving line of credit with BMO Bank N.A.; no balance was outstanding as of September 30, 2026. The entire facility is available to meet AtlasClearing’s liquidity requirements for NSCC clearing margin deposits.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false Q1 --06-30 2027 0001963088 0001963088 2026-07-01 2026-09-30 0001963088 2026-11-03 0001963088 2026-09-30 0001963088 2026-06-30 0001963088 2025-07-01 2025-09-30 0001963088 us-gaap:CommonStockMember 2026-06-30 0001963088 ATCH:SubscriptionReceivableMember 2026-06-30 0001963088 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0001963088 us-gaap:RetainedEarningsMember 2026-06-30 0001963088 us-gaap:CommonStockMember 2025-06-30 0001963088 ATCH:SubscriptionReceivableMember 2025-06-30 0001963088 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001963088 us-gaap:RetainedEarningsMember 2025-06-30 0001963088 2025-06-30 0001963088 us-gaap:CommonStockMember 2026-07-01 2026-09-30 0001963088 ATCH:SubscriptionReceivableMember 2026-07-01 2026-09-30 0001963088 us-gaap:AdditionalPaidInCapitalMember 2026-07-01 2026-09-30 0001963088 us-gaap:RetainedEarningsMember 2026-07-01 2026-09-30 0001963088 us-gaap:CommonStockMember ATCH:MergerFinancingMember 2025-07-01 2025-09-30 0001963088 ATCH:SubscriptionReceivableMember ATCH:MergerFinancingMember 2025-07-01 2025-09-30 0001963088 us-gaap:AdditionalPaidInCapitalMember ATCH:MergerFinancingMember 2025-07-01 2025-09-30 0001963088 us-gaap:RetainedEarningsMember ATCH:MergerFinancingMember 2025-07-01 2025-09-30 0001963088 ATCH:MergerFinancingMember 2025-07-01 2025-09-30 0001963088 us-gaap:CommonStockMember us-gaap:SecuredDebtMember 2025-07-01 2025-09-30 0001963088 ATCH:SubscriptionReceivableMember us-gaap:SecuredDebtMember 2025-07-01 2025-09-30 0001963088 us-gaap:AdditionalPaidInCapitalMember us-gaap:SecuredDebtMember 2025-07-01 2025-09-30 0001963088 us-gaap:RetainedEarningsMember us-gaap:SecuredDebtMember 2025-07-01 2025-09-30 0001963088 us-gaap:SecuredDebtMember 2025-07-01 2025-09-30 0001963088 us-gaap:CommonStockMember us-gaap:ConvertibleDebtMember 2025-07-01 2025-09-30 0001963088 ATCH:SubscriptionReceivableMember us-gaap:ConvertibleDebtMember 2025-07-01 2025-09-30 0001963088 us-gaap:AdditionalPaidInCapitalMember us-gaap:ConvertibleDebtMember 2025-07-01 2025-09-30 0001963088 us-gaap:RetainedEarningsMember us-gaap:ConvertibleDebtMember 2025-07-01 2025-09-30 0001963088 us-gaap:ConvertibleDebtMember 2025-07-01 2025-09-30 0001963088 us-gaap:CommonStockMember 2025-07-01 2025-09-30 0001963088 ATCH:SubscriptionReceivableMember 2025-07-01 2025-09-30 0001963088 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0001963088 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0001963088 us-gaap:CommonStockMember ATCH:PromissoryNoteMember 2025-07-01 2025-09-30 0001963088 ATCH:SubscriptionReceivableMember ATCH:PromissoryNoteMember 2025-07-01 2025-09-30 0001963088 us-gaap:AdditionalPaidInCapitalMember ATCH:PromissoryNoteMember 2025-07-01 2025-09-30 0001963088 us-gaap:RetainedEarningsMember ATCH:PromissoryNoteMember 2025-07-01 2025-09-30 0001963088 ATCH:PromissoryNoteMember 2025-07-01 2025-09-30 0001963088 us-gaap:CommonStockMember 2026-09-30 0001963088 ATCH:SubscriptionReceivableMember 2026-09-30 0001963088 us-gaap:AdditionalPaidInCapitalMember 2026-09-30 0001963088 us-gaap:RetainedEarningsMember 2026-09-30 0001963088 us-gaap:CommonStockMember 2025-09-30 0001963088 ATCH:SubscriptionReceivableMember 2025-09-30 0001963088 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0001963088 us-gaap:RetainedEarningsMember 2025-09-30 0001963088 2025-09-30 0001963088 us-gaap:ConvertibleDebtMember 2026-07-01 2026-09-30 0001963088 us-gaap:SecuredDebtMember 2026-07-01 2026-09-30 0001963088 ATCH:ShortTermNoteMember 2026-07-01 2026-09-30 0001963088 ATCH:ShortTermNoteMember 2025-07-01 2025-09-30 0001963088 ATCH:LongTermNotesAndMergerFinancingMember 2026-07-01 2026-09-30 0001963088 ATCH:LongTermNotesAndMergerFinancingMember 2025-07-01 2025-09-30 0001963088 ATCH:PromissoryNotesMember 2026-07-01 2026-09-30 0001963088 ATCH:PromissoryNotesMember 2025-07-01 2025-09-30 0001963088 us-gaap:SubsequentEventMember 2026-10-31 0001963088 us-gaap:SubsequentEventMember 2026-10-31 2026-10-31 0001963088 srt:MinimumMember 2026-09-30 0001963088 srt:MaximumMember 2026-09-30 0001963088 ATCH:DevelopedTechnologyMember 2026-09-30 0001963088 us-gaap:CustomerListsMember 2026-09-30 0001963088 ATCH:DevelopedTechnologyMember 2026-06-30 0001963088 us-gaap:CustomerListsMember 2026-06-30 0001963088 ATCH:DebentureMember 2026-07-01 2026-09-30 0001963088 ATCH:DebentureMember 2025-07-01 2025-09-30 0001963088 ATCH:SecuredConvertibleNotesMember 2026-07-01 2026-09-30 0001963088 ATCH:SecuredConvertibleNotesMember 2025-07-01 2025-09-30 0001963088 ATCH:SubscriptionAgreementMember 2026-07-01 2026-09-30 0001963088 ATCH:SubscriptionAgreementMember 2025-07-01 2025-09-30 0001963088 ATCH:PromissoryNoteMember 2026-07-01 2026-09-30 0001963088 us-gaap:ConvertibleDebtSecuritiesMember 2026-07-01 2026-09-30 0001963088 us-gaap:ConvertibleDebtSecuritiesMember 2025-07-01 2025-09-30 0001963088 ATCH:PerformanceBasedMarketConditionStockAwardsMember 2026-07-01 2026-09-30 0001963088 ATCH:PerformanceBasedMarketConditionStockAwardsMember 2025-07-01 2025-09-30 0001963088 ATCH:TimeBasedStockAwardsMember 2026-07-01 2026-09-30 0001963088 ATCH:TimeBasedStockAwardsMember 2025-07-01 2025-09-30 0001963088 ATCH:InTheMoneyStockOptionsMember 2026-07-01 2026-09-30 0001963088 ATCH:InTheMoneyStockOptionsMember 2025-07-01 2025-09-30 0001963088 ATCH:PublicWarrantsMember 2026-07-01 2026-09-30 0001963088 ATCH:PublicWarrantsMember 2025-07-01 2025-09-30 0001963088 ATCH:PrivateWarrantsMember 2026-07-01 2026-09-30 0001963088 ATCH:PrivateWarrantsMember 2025-07-01 2025-09-30 0001963088 ATCH:SecuredConvertibleNoteWarrantsMember 2026-07-01 2026-09-30 0001963088 ATCH:SecuredConvertibleNoteWarrantsMember 2025-07-01 2025-09-30 0001963088 ATCH:WarrantsLiabilityMember 2026-07-01 2026-09-30 0001963088 ATCH:WarrantsLiabilityMember 2025-07-01 2025-09-30 0001963088 ATCH:CustomersTransactionsAndCreditBalancesMember 2026-09-30 0001963088 ATCH:CustomersTransactionsAndCreditBalancesMember 2026-06-30 0001963088 ATCH:CustomersTransactionsAndCreditBalancesMember us-gaap:SubsequentEventMember 2026-10-01 0001963088 ATCH:CustomersTransactionsAndCreditBalancesMember 2026-07-01 0001963088 ATCH:BrokerDealerTransactionsAndCreditBalancesMember 2026-09-30 0001963088 ATCH:BrokerDealerTransactionsAndCreditBalancesMember 2026-06-30 0001963088 ATCH:BrokerDealerTransactionsAndCreditBalancesMember us-gaap:SubsequentEventMember 2026-10-01 0001963088 ATCH:BrokerDealerTransactionsAndCreditBalancesMember 2026-07-01 0001963088 us-gaap:GoodwillMember 2026-09-30 0001963088 us-gaap:GoodwillMember 2026-07-01 2026-09-30 0001963088 us-gaap:DevelopedTechnologyRightsMember 2026-09-30 0001963088 us-gaap:DevelopedTechnologyRightsMember 2026-07-01 2026-09-30 0001963088 us-gaap:CustomerListsMember 2026-09-30 0001963088 us-gaap:CustomerListsMember 2026-07-01 2026-09-30 0001963088 us-gaap:GoodwillMember 2026-06-30 0001963088 us-gaap:GoodwillMember 2025-07-01 2026-06-30 0001963088 us-gaap:DevelopedTechnologyRightsMember 2026-06-30 0001963088 us-gaap:DevelopedTechnologyRightsMember 2025-07-01 2026-06-30 0001963088 us-gaap:CustomerListsMember 2026-06-30 0001963088 us-gaap:CustomerListsMember 2025-07-01 2026-06-30 0001963088 2025-07-01 2026-06-30 0001963088 ATCH:QuantumVenturesLLCMember 2024-05-09 2024-05-09 0001963088 ATCH:QuantumVenturesLLCMember 2024-05-09 0001963088 srt:BoardOfDirectorsChairmanMember 2026-09-30 0001963088 srt:BoardOfDirectorsChairmanMember 2026-06-30 0001963088 srt:PresidentMember 2026-09-30 0001963088 srt:PresidentMember 2026-06-30 0001963088 ATCH:SixthBoroughCapitalFundLpMember us-gaap:ConvertibleDebtMember us-gaap:RelatedPartyMember 2025-09-30 0001963088 ATCH:GeneralCounselAndChiefFinancialOfficerMember us-gaap:ConvertibleDebtMember us-gaap:RelatedPartyMember 2025-09-30 0001963088 ATCH:SandipPatelMember us-gaap:RelatedPartyMember 2025-10-08 0001963088 ATCH:SixthBoroughCapitalFundLpMember us-gaap:RelatedPartyMember 2025-10-08 0001963088 2025-10-08 2025-10-08 0001963088 ATCH:SandipIPatelPAMember 2025-07-17 2025-07-17 0001963088 ATCH:SandipIPatelPAMember 2025-07-17 0001963088 2025-07-17 0001963088 us-gaap:NonrelatedPartyMember 2025-07-17 0001963088 ATCH:SeriesAConvertibleDebenturesMember ATCH:AugustSecuritiesPurchaseAgreementMember 2025-08-04 0001963088 ATCH:SeriesAConvertibleDebenturesMember ATCH:AugustSecuritiesPurchaseAgreementMember 2025-08-04 2025-08-04 0001963088 ATCH:SeriesAConvertibleDebenturesMember ATCH:AugustSecuritiesPurchaseAgreementMember 2026-09-30 0001963088 ATCH:SeriesAConvertibleDebenturesMember ATCH:AugustSecuritiesPurchaseAgreementMember 2026-07-01 2026-09-30 0001963088 ATCH:SeriesAConvertibleDebenturesMember ATCH:AugustSecuritiesPurchaseAgreementMember 2025-07-01 2025-09-30 0001963088 ATCH:SeriesAConvertibleDebenturesMember ATCH:AugustSecuritiesPurchaseAgreementMember 2026-06-30 0001963088 ATCH:ChardanCapitalMarketsLLCMember 2026-07-01 2026-09-30 0001963088 srt:MinimumMember ATCH:ChardanCapitalMarketsLLCMember 2026-09-30 0001963088 srt:MaximumMember ATCH:ChardanCapitalMarketsLLCMember 2026-09-30 0001963088 ATCH:ChardanNoteMember 2026-07-01 2026-09-30 0001963088 ATCH:ChardanNoteMember 2026-09-30 0001963088 ATCH:ChardanNoteMember 2026-06-30 0001963088 ATCH:FunicularNoteMember 2025-10-08 0001963088 ATCH:FunicularNoteMember 2025-10-08 2025-10-08 0001963088 ATCH:FunicularNoteMember 2026-07-01 2026-09-30 0001963088 ATCH:FunicularNoteMember 2026-09-30 0001963088 ATCH:PromissoryNotesMember ATCH:InterestSolutionsLLCMember 2024-02-09 0001963088 ATCH:PromissoryNotesMember ATCH:InterestSolutionsLLCMember 2024-02-09 2024-02-09 0001963088 ATCH:PromissoryNotesMember ATCH:InterestSolutionsLLCMember 2026-07-01 2026-09-30 0001963088 ATCH:PromissoryNotesMember ATCH:InterestSolutionsLLCMember 2025-07-01 2025-09-30 0001963088 ATCH:PromissoryNotesMember ATCH:JonesTradingInstitutionalServicesLLCMember 2024-02-09 0001963088 ATCH:PromissoryNotesMember ATCH:JonesTradingInstitutionalServicesLLCMember 2026-07-01 2026-09-30 0001963088 ATCH:PromissoryNotesMember ATCH:JonesTradingInstitutionalServicesLLCMember 2025-07-01 2025-09-30 0001963088 ATCH:HanirePurchaseAgreementMember 2026-06-30 0001963088 ATCH:HanirePurchaseAgreementMember 2026-09-30 0001963088 ATCH:PremiumFinncingAgreementMember 2026-09-30 0001963088 ATCH:PremiumFinncingAgreementMember 2026-06-30 0001963088 ATCH:PremiumFinncingAgreementMember 2026-07-01 2026-09-30 0001963088 2025-10-08 0001963088 us-gaap:CommonStockMember 2025-10-09 2025-10-14 0001963088 ATCH:TwoThousandTwentyFiveWarrantMember 2025-10-09 2025-10-14 0001963088 ATCH:TwoThousandTwentyFiveWarrantMember 2025-10-08 0001963088 ATCH:TwoThousandTwentyFiveWarrantMember 2025-10-08 2025-10-08 0001963088 2025-10-09 2025-10-14 0001963088 ATCH:SubordinatedLoanAgreementsMember 2026-09-30 0001963088 ATCH:SixSubordinatedLoanAgreementsMember 2025-09-30 0001963088 ATCH:SubordinatedDemandNotesMember 2026-09-30 0001963088 ATCH:AtlasclearInc.Member 2024-02-09 2024-02-09 0001963088 ATCH:AtlasclearInc.Member 2024-02-09 0001963088 ATCH:AtlasFintechMember ATCH:AtlasclearInc.Member 2024-02-09 0001963088 ATCH:AtlasFintechMember ATCH:AtlasclearInc.Member 2024-02-09 2024-02-09 0001963088 ATCH:JohnSchaibleAndCraigRidenhourMember 2025-09-19 2025-09-19 0001963088 2025-09-19 0001963088 ATCH:JohnSchaibleAndCraigRidenhourMember ATCH:PayableImmediatelyMember 2025-09-19 2025-09-19 0001963088 ATCH:JohnSchaibleAndCraigRidenhourMember 2025-09-19 0001963088 ATCH:JohnSchaibleAndCraigRidenhourMember ATCH:PayableAtEndOfFirstQuarter2026Member 2025-09-19 2025-09-19 0001963088 ATCH:JohnSchaibleAndCraigRidenhourMember ATCH:GrantedOnSigningMember 2025-09-19 2025-09-19 0001963088 ATCH:JohnSchaibleAndCraigRidenhourMember ATCH:GrantedOnJuly12026Member 2025-09-19 2025-09-19 0001963088 ATCH:JohnSchaibleAndCraigRidenhourMember ATCH:StockPriceMilestoneOneMember 2025-09-19 0001963088 ATCH:JohnSchaibleAndCraigRidenhourMember ATCH:StockPriceMilestoneTwoMember 2025-09-19 0001963088 ATCH:JohnSchaibleAndCraigRidenhourMember ATCH:StockPriceMilestoneThreeMember 2025-09-19 0001963088 ATCH:JohnSchaibleAndCraigRidenhourMember ATCH:StockPriceMilestoneFourMember 2025-09-19 0001963088 ATCH:JohnSchaibleAndCraigRidenhourMember ATCH:StockPriceMilestoneFiveMember 2025-09-19 0001963088 ATCH:SandipPatelMember 2025-09-24 2025-09-24 0001963088 ATCH:SandipPatelMember 2025-09-24 0001963088 ATCH:SandipPatelMember ATCH:StockPriceMilestoneOneMember 2025-09-24 0001963088 ATCH:SandipPatelMember ATCH:StockPriceMilestoneTwoMember 2025-09-24 0001963088 ATCH:SandipPatelMember ATCH:StockPriceMilestoneThreeMember 2025-09-24 0001963088 ATCH:SandipPatelMember ATCH:StockPriceMilestoneFourMember 2025-09-24 0001963088 ATCH:SandipPatelMember ATCH:StockPriceMilestoneFiveMember 2025-09-24 0001963088 2026-02-05 0001963088 us-gaap:LineOfCreditMember 2026-09-30 0001963088 us-gaap:LineOfCreditMember 2026-07-01 2026-09-30 0001963088 ATCH:WilsonDavisCoIncMember 2018-02-27 2018-02-27 0001963088 ATCH:WilsonDavisCoIncMember 2019-12-19 2019-12-19 0001963088 ATCH:WilsonDavisCoIncMember 2025-07-10 2025-07-10 0001963088 ATCH:WilsonDavisCoIncMember 2025-07-10 0001963088 2025-06-10 2025-06-10 0001963088 2025-06-10 0001963088 ATCH:InvestorWarrantsMember 2025-10-08 2025-10-08 0001963088 ATCH:PlacementAgentWarrantsMember 2025-10-08 2025-10-08 0001963088 ATCH:PublicWarrantsMember 2024-02-09 2024-02-09 0001963088 ATCH:PrivateWarrantsMember 2024-02-09 2024-02-09 0001963088 ATCH:SecuredConvertibleNoteWarrantsMember 2024-02-09 2024-02-09 0001963088 us-gaap:WarrantMember 2026-07-01 2026-09-30 0001963088 us-gaap:WarrantMember 2025-07-01 2026-06-30 0001963088 ATCH:InvestorWarrantsMember us-gaap:WarrantMember 2026-06-30 0001963088 ATCH:InvestorWarrantsMember us-gaap:WarrantMember 2026-07-01 2026-09-30 0001963088 ATCH:InvestorWarrantsMember us-gaap:WarrantMember 2026-09-30 0001963088 ATCH:PlacementAgentMember us-gaap:WarrantMember 2026-06-30 0001963088 ATCH:PlacementAgentMember us-gaap:WarrantMember 2026-07-01 2026-09-30 0001963088 ATCH:PlacementAgentMember us-gaap:WarrantMember 2026-09-30 0001963088 ATCH:PublicWarrantsMember us-gaap:WarrantMember 2026-06-30 0001963088 ATCH:PublicWarrantsMember us-gaap:WarrantMember 2026-07-01 2026-09-30 0001963088 ATCH:PublicWarrantsMember us-gaap:WarrantMember 2026-09-30 0001963088 ATCH:PrivateWarrantsMember us-gaap:WarrantMember 2026-06-30 0001963088 ATCH:PrivateWarrantsMember us-gaap:WarrantMember 2026-07-01 2026-09-30 0001963088 ATCH:PrivateWarrantsMember us-gaap:WarrantMember 2026-09-30 0001963088 ATCH:SecuredNoteWarrantsMember us-gaap:WarrantMember 2026-06-30 0001963088 ATCH:SecuredNoteWarrantsMember us-gaap:WarrantMember 2026-07-01 2026-09-30 0001963088 ATCH:SecuredNoteWarrantsMember us-gaap:WarrantMember 2026-09-30 0001963088 us-gaap:WarrantMember 2026-06-30 0001963088 us-gaap:WarrantMember 2026-09-30 0001963088 2026-05-27 0001963088 ATCH:EquityIncentivePlanMember 2026-05-27 0001963088 ATCH:TimeBasedStockAwardsMember 2026-07-01 2026-09-30 0001963088 us-gaap:PerformanceSharesMember 2026-09-30 2026-09-30 0001963088 ATCH:JulyTwoThousandTwentySixGrantsMember us-gaap:MeasurementInputSharePriceMember 2026-09-30 0001963088 ATCH:JulyTwoThousandTwentySixGrantsMember us-gaap:MeasurementInputExercisePriceMember 2026-09-30 0001963088 ATCH:MeasurementInputExpectedVolatilityMember ATCH:JulyTwoThousandTwentySixGrantsMember 2026-09-30 0001963088 us-gaap:MeasurementInputRiskFreeInterestRateMember ATCH:JulyTwoThousandTwentySixGrantsMember 2026-09-30 0001963088 us-gaap:MeasurementInputExpectedTermMember ATCH:JulyTwoThousandTwentySixGrantsMember 2026-09-30 0001963088 ATCH:MeasurementInputExpectedDividendYieldMember ATCH:JulyTwoThousandTwentySixGrantsMember 2026-09-30 0001963088 2026-01-01 2026-09-30 0001963088 ATCH:TimeBasedStockAwardsMember 2026-07-13 2026-09-30 0001963088 ATCH:TimeBasedStockAwardsMember 2026-09-30 0001963088 ATCH:TimeBasedStockAwardsMember 2025-07-01 2025-09-30 0001963088 us-gaap:PerformanceSharesMember 2026-07-01 2026-09-30 0001963088 us-gaap:PerformanceSharesMember 2025-07-01 2025-09-30 0001963088 us-gaap:FairValueInputsLevel1Member 2026-09-30 0001963088 us-gaap:FairValueInputsLevel1Member 2026-06-30 0001963088 us-gaap:FairValueInputsLevel3Member 2026-09-30 0001963088 us-gaap:FairValueInputsLevel3Member 2026-06-30 0001963088 us-gaap:FairValueInputsLevel3Member ATCH:DebentureMember 2026-09-30 0001963088 us-gaap:FairValueInputsLevel3Member ATCH:DebentureMember 2026-06-30 0001963088 us-gaap:FairValueInputsLevel3Member ATCH:SecuredConvertibleNoteMember 2026-09-30 0001963088 us-gaap:FairValueInputsLevel3Member ATCH:SecuredConvertibleNoteMember 2026-06-30 0001963088 us-gaap:MeasurementInputSharePriceMember 2026-09-30 0001963088 us-gaap:MeasurementInputSharePriceMember 2026-06-30 0001963088 us-gaap:MeasurementInputRiskFreeInterestRateMember 2026-09-30 0001963088 us-gaap:MeasurementInputRiskFreeInterestRateMember 2026-06-30 0001963088 us-gaap:MeasurementInputExpectedDividendRateMember 2026-09-30 0001963088 us-gaap:MeasurementInputExpectedDividendRateMember 2026-06-30 0001963088 us-gaap:MeasurementInputPriceVolatilityMember 2026-09-30 0001963088 us-gaap:MeasurementInputPriceVolatilityMember 2026-06-30 0001963088 us-gaap:MeasurementInputExercisePriceMember 2026-09-30 0001963088 us-gaap:MeasurementInputExercisePriceMember 2026-06-30 0001963088 us-gaap:MeasurementInputExpectedTermMember 2026-07-01 2026-09-30 0001963088 us-gaap:MeasurementInputExpectedTermMember 2025-07-01 2026-06-30 0001963088 us-gaap:MeasurementInputDiscountRateMember 2026-09-30 0001963088 us-gaap:MeasurementInputDiscountRateMember 2026-06-30 0001963088 us-gaap:MeasurementInputSharePriceMember ATCH:SecuredConvertibleNoteMember 2026-09-30 0001963088 us-gaap:MeasurementInputSharePriceMember ATCH:SecuredConvertibleNoteMember 2026-06-30 0001963088 us-gaap:MeasurementInputConversionPriceMember ATCH:SecuredConvertibleNoteMember 2026-09-30 0001963088 us-gaap:MeasurementInputConversionPriceMember ATCH:SecuredConvertibleNoteMember 2026-06-30 0001963088 ATCH:MeasurementInputInterestBalanceMember ATCH:SecuredConvertibleNoteMember 2026-09-30 0001963088 ATCH:MeasurementInputInterestBalanceMember ATCH:SecuredConvertibleNoteMember 2026-06-30 0001963088 us-gaap:MeasurementInputRiskFreeInterestRateMember ATCH:SecuredConvertibleNoteMember 2026-09-30 0001963088 us-gaap:MeasurementInputRiskFreeInterestRateMember ATCH:SecuredConvertibleNoteMember 2026-06-30 0001963088 us-gaap:MeasurementInputDiscountRateMember ATCH:SecuredConvertibleNoteMember 2026-09-30 0001963088 us-gaap:MeasurementInputDiscountRateMember ATCH:SecuredConvertibleNoteMember 2026-06-30 0001963088 us-gaap:MeasurementInputPriceVolatilityMember ATCH:SecuredConvertibleNoteMember 2026-09-30 0001963088 us-gaap:MeasurementInputPriceVolatilityMember ATCH:SecuredConvertibleNoteMember 2026-06-30 0001963088 ATCH:SecuredConvertibleNoteMember us-gaap:MeasurementInputExpectedTermMember 2026-07-01 2026-09-30 0001963088 ATCH:SecuredConvertibleNoteMember us-gaap:MeasurementInputExpectedTermMember 2025-07-01 2026-06-30 0001963088 ATCH:SecuredConvertibleNoteMember us-gaap:MeasurementInputExpectedTermMember 2026-09-30 0001963088 ATCH:SecuredConvertibleNoteMember us-gaap:MeasurementInputExpectedTermMember 2026-06-30 0001963088 us-gaap:MeasurementInputSharePriceMember ATCH:DebentureMember 2026-09-30 0001963088 us-gaap:MeasurementInputSharePriceMember ATCH:DebentureMember 2026-06-30 0001963088 us-gaap:MeasurementInputRiskFreeInterestRateMember ATCH:DebentureMember 2026-09-30 0001963088 us-gaap:MeasurementInputRiskFreeInterestRateMember ATCH:DebentureMember 2026-06-30 0001963088 us-gaap:MeasurementInputDiscountRateMember ATCH:DebentureMember 2026-09-30 0001963088 us-gaap:MeasurementInputDiscountRateMember ATCH:DebentureMember 2026-06-30 0001963088 us-gaap:MeasurementInputPriceVolatilityMember ATCH:DebentureMember 2026-09-30 0001963088 us-gaap:MeasurementInputPriceVolatilityMember ATCH:DebentureMember 2026-06-30 0001963088 ATCH:DebentureMember us-gaap:MeasurementInputExpectedTermMember 2026-07-01 2026-09-30 0001963088 ATCH:DebentureMember us-gaap:MeasurementInputExpectedTermMember 2025-07-01 2026-06-30 0001963088 us-gaap:MeasurementInputSharePriceMember ATCH:TwoThousandTwentyFiveWarrantLiabilityMember 2026-09-30 0001963088 us-gaap:MeasurementInputSharePriceMember ATCH:TwoThousandTwentyFiveWarrantLiabilityMember 2026-06-30 0001963088 us-gaap:MeasurementInputRiskFreeInterestRateMember ATCH:TwoThousandTwentyFiveWarrantLiabilityMember 2026-09-30 0001963088 us-gaap:MeasurementInputRiskFreeInterestRateMember ATCH:TwoThousandTwentyFiveWarrantLiabilityMember 2026-06-30 0001963088 us-gaap:MeasurementInputExpectedDividendRateMember ATCH:TwoThousandTwentyFiveWarrantLiabilityMember 2026-09-30 0001963088 us-gaap:MeasurementInputExpectedDividendRateMember ATCH:TwoThousandTwentyFiveWarrantLiabilityMember 2026-06-30 0001963088 us-gaap:MeasurementInputPriceVolatilityMember ATCH:TwoThousandTwentyFiveWarrantLiabilityMember 2026-09-30 0001963088 us-gaap:MeasurementInputPriceVolatilityMember ATCH:TwoThousandTwentyFiveWarrantLiabilityMember 2026-06-30 0001963088 us-gaap:MeasurementInputExercisePriceMember ATCH:TwoThousandTwentyFiveWarrantLiabilityMember 2026-09-30 0001963088 us-gaap:MeasurementInputExercisePriceMember ATCH:TwoThousandTwentyFiveWarrantLiabilityMember 2026-06-30 0001963088 ATCH:TwoThousandTwentyFiveWarrantLiabilityMember us-gaap:MeasurementInputExpectedTermMember 2026-09-30 0001963088 ATCH:TwoThousandTwentyFiveWarrantLiabilityMember us-gaap:MeasurementInputExpectedTermMember 2026-06-30 0001963088 ATCH:TwoThousandTwentyFiveWarrantLiabilityMember us-gaap:MeasurementInputExpectedTermMember 2026-07-01 2026-09-30 0001963088 ATCH:TwoThousandTwentyFiveWarrantLiabilityMember us-gaap:MeasurementInputExpectedTermMember 2025-07-01 2026-06-30 0001963088 ATCH:SecuredConvertibleNoteMember 2025-09-30 0001963088 ATCH:DebentureMember 2026-09-30 0001963088 ATCH:DebentureMember 2025-08-04 0001963088 ATCH:SecuritiesPurchaseAgreementMember ATCH:TwoThousandTwentyFiveWarrantLiabilityMember 2025-10-08 2025-10-08 0001963088 ATCH:SecuritiesPurchaseAgreementMember ATCH:TwoThousandTwentyFiveWarrantLiabilityMember 2025-10-08 0001963088 ATCH:TwoThousandTwentyFiveWarrantLiabilityMember 2025-10-08 2025-10-08 0001963088 ATCH:PrivateWarrantsMember 2026-06-30 0001963088 ATCH:EarnoutLiabilityMember 2026-06-30 0001963088 ATCH:PrivateWarrantsMember 2026-07-01 2026-09-30 0001963088 ATCH:EarnoutLiabilityMember 2026-07-01 2026-09-30 0001963088 ATCH:PrivateWarrantsMember 2026-09-30 0001963088 ATCH:EarnoutLiabilityMember 2026-09-30 0001963088 ATCH:PrivateWarrantsMember 2025-06-30 0001963088 ATCH:TauAgreementMember 2025-06-30 0001963088 ATCH:PrivateWarrantsMember 2025-07-01 2025-09-30 0001963088 ATCH:TauAgreementMember 2025-07-01 2025-09-30 0001963088 ATCH:PrivateWarrantsMember 2025-09-30 0001963088 ATCH:TauAgreementMember 2025-09-30 0001963088 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2025-06-30 0001963088 ATCH:EarnoutLiabilityMember 2025-06-30 0001963088 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2025-07-01 2025-09-30 0001963088 ATCH:EarnoutLiabilityMember 2025-07-01 2025-09-30 0001963088 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2025-09-30 0001963088 ATCH:EarnoutLiabilityMember 2025-09-30 0001963088 ATCH:WinstonAndStrawnAgreementMember 2025-06-30 0001963088 ATCH:MergerFinancingDerivativeMember 2025-06-30 0001963088 ATCH:WinstonAndStrawnAgreementMember 2025-07-01 2025-09-30 0001963088 ATCH:MergerFinancingDerivativeMember 2025-07-01 2025-09-30 0001963088 ATCH:WinstonAndStrawnAgreementMember 2025-09-30 0001963088 ATCH:MergerFinancingDerivativeMember 2025-09-30 0001963088 ATCH:DebentureDerivativeMember 2026-06-30 0001963088 ATCH:DebentureDerivativeMember 2026-07-01 2026-09-30 0001963088 ATCH:DebentureDerivativeMember 2026-09-30 0001963088 ATCH:DebentureDerivativeMember 2025-06-30 0001963088 ATCH:ConvertibleNoteDerivativeMember 2025-06-30 0001963088 ATCH:DebentureDerivativeMember 2025-07-01 2025-09-30 0001963088 ATCH:ConvertibleNoteDerivativeMember 2025-07-01 2025-09-30 0001963088 ATCH:DebentureDerivativeMember 2025-09-30 0001963088 ATCH:ConvertibleNoteDerivativeMember 2025-09-30 0001963088 ATCH:SecuredConvertibleNoteMember 2026-06-30 0001963088 ATCH:WarrantLiabilityMember 2026-06-30 0001963088 ATCH:SecuredConvertibleNoteMember 2026-07-01 2026-09-30 0001963088 ATCH:WarrantLiabilityMember 2026-07-01 2026-09-30 0001963088 ATCH:SecuredConvertibleNoteMember 2026-09-30 0001963088 ATCH:WarrantLiabilityMember 2026-09-30 0001963088 ATCH:SingleReportableSegmentMember 2026-07-01 2026-09-30 0001963088 us-gaap:SubsequentEventMember 2026-10-14 2026-10-14 0001963088 us-gaap:SubsequentEventMember 2026-10-14 0001963088 us-gaap:SubsequentEventMember ATCH:DebentureAgreementMember 2026-10-14 0001963088 ATCH:ArkFinancialServicesIncMember us-gaap:SubsequentEventMember 2026-10-14 0001963088 us-gaap:SubsequentEventMember 2026-10-01 2026-10-01 0001963088 us-gaap:SubsequentEventMember ATCH:SubordinatedLoanAgreementsMember 2026-11-13 0001963088 us-gaap:SubsequentEventMember ATCH:TwoSubordinatedLoanAgreementsMember 2026-11-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure ATCH:ITEM ATCH:Integer

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(MARK ONE)

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2026

 

or

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from          to         

 

Commission File Number: 001-41956

 

AtlasClear Holdings, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   92-2303797

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

     

4350 West Cypress Street, Suite 270

Tampa, FL

  33607
(Address of principal executive offices)   (Zip Code)

 

(727) 446-6660

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class  

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common stock, $0.0001 par value per share   ATCH   NYSE American LLC1

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
       
Non-accelerated filer ☒ Smaller reporting company ☒
       
    Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ☐ No ☒

 

As of November 3, 2026  , there were 151,838,744 shares of common stock, $0.0001 par value, issued and outstanding.

 

 

1 On November 10, 2026, AtlasClear Holdings, Inc. (the “Company”) received notice from NYSE Regulation of the NYSE American LLC (“NYSE American”) that it had suspended trading of the Company’s common stock and determined to commence proceedings to delist the Company’s common stock from the NYSE American as a result of its determination that the Company is no longer suitable for listing pursuant to Section 1003(f)(v) of the NYSE American Company Guide due to the low selling price of the Company’s common stock. The Company has a right to a review of NYSE American’s determination to delist the Company’s common stock by the Listings Qualifications Panel of the Committee for Review of the Board of Directors of the NYSE American, and the Company intends to request such a review; however, there can be no assurance that any such appeal will be successful. Since November 11, 2026, the Company’s common stock has traded on the OTC Pink Limited Market.

 

 

 

 
Table of Contents

 

ATLASCLEAR HOLDINGS, INC.

FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2026

TABLE OF CONTENTS

 

  Page
Part I. Financial Information 3
Item 1. Interim Consolidated Financial Statements 3
Condensed Consolidated Balance Sheets as of September 30, 2026 (unaudited) and June 30, 2026 3
Condensed Consolidated Statements of Operations for the three months ended September 30, 2026 and 2025 (Unaudited) 4
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) for the three months ended September 30, 2026 and 2025 (Unaudited) 5
Condensed Consolidated Statements of Cash Flows for the three months ended September 30, 2026 and 2025 (Unaudited) 6
Notes to Condensed Consolidated Financial Statements (Unaudited) 8
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 35
Item 3. Quantitative and Qualitative Disclosures About Market Risk 42
Item 4. Controls and Procedures 42
Part II. Other Information 43
Item 1. Legal Proceedings 43
Item 1A. Risk Factors 43
Item 2. Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities 44
Item 3. Defaults Upon Senior Securities 44
Item 4. Mine Safety Disclosures 44
Item 5. Other Information 44
Item 6. Exhibits 44
Signatures 45

 

2
Table of Contents

 

PART I - FINANCIAL INFORMATION

 

Item 1. Interim Consolidated Financial Statements.

 

ATLASCLEAR HOLDINGS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

 

   September 30,   June 30, 
   2026   2026 
    (Unaudited)      
ASSETS          
Cash and cash equivalents  $9,431,777   $15,422,176 
Cash segregated - customers   26,022,634    24,041,343 
Cash segregated - PAB   383,751    378,962 
Receivables - broker-dealers and clearing organizations   1,390,683    3,858,093 
Receivables - customers, net of allowance for credit losses of $401,128, and $401,128 as of September 30, 2026 and June 30, 2026, respectively   6,353,490    854,929 
Other receivables   87,075    41,646 
Prepaids   247,890    416,825 
Trading securities, market value, net   76    — 
Total Current Assets   43,917,376    45,013,974 
           
Operating lease right to use lease asset   577,864    668,325 
Customer list, net   11,406,164    11,713,356 
Goodwill   6,142,525    6,142,525 
Developed technology, net   1,543,674    1,592,277 
Cash deposits - broker-dealers and clearing organizations   5,012,500    5,012,500 
Bank acquisition deposit   128,645    128,645 
Other assets   1,085,105    957,081 
TOTAL ASSETS  $69,813,853   $71,228,683 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)          
LIABILITIES          
Payables to customers  $25,037,327   $23,555,303 
Accounts and payables to officers/directors   —    47,300 
Accounts payable and accrued expenses   3,201,915    3,862,149 
Payables - broker-dealers and clearing organizations   3,844    40 
Commissions, payroll and payroll taxes   441,391    923,840 
Current portion of lease liability   266,278    301,622 
Promissory notes   293,224    430,484 
Debenture   557,769    515,661 
Debenture – derivative   362,095    252,374 
Subordinated borrowings-current   

1,930,000

    

—

 
Stock payable – related party   55,087    55,087 
Total Current Liabilities   32,148,930    29,943,860 
           
Accrued contingent liability   100,000    100,000 
Long-term secured convertible note, net   10,847,883    11,210,358 
 Warrant Liability   2,724,340    3,013,367 
Derivative liability - warrants   110,757    184,588 
Earnout - liability   14,000    263,000 
Deferred income tax liability   2,828,782    3,063,850 
Subordinated borrowings   —    1,930,000 
Long-term lease liability   326,641    379,387 
TOTAL LIABILITIES   49,101,333    50,088,410 
           
Commitments and Contingencies (Note 10)   -     -  
           
STOCKHOLDERS’ EQUITY (DEFICIT)          
Preferred stock, $0.0001 par value; 25,000,000 shares authorized; none issued or outstanding at September 30, 2026 and June 30, 2026   —    — 
Common stock, $0.0001 par value; 500,000,000 shares authorized; 151,838,744 and 150,337,774 shares issued and outstanding at September 30, 2026 and June 30, 2026, respectively   15,183    15,033 
Stock subscription receivable   (41,089)   (41,089)
Additional paid-in-capital   159,740,724    159,115,656 
Accumulated Deficit   (139,002,298)   (137,949,327)
TOTAL STOCKHOLDERS’ EQUITY (DEFICIT)   20,712,520    21,140,273 
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)  $69,813,853   $71,228,683 

 

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

 

3
Table of Contents

 

ATLASCLEAR HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

 

   2026   2025 
   Three Months Ended 
   September 30, 
   2026   2025 
REVENUES          
Commissions  $1,736,434   $2,334,389 
Vetting fees   230,015    371,700 
Clearing fees   101,786    714,349 
Stock locate fees   2,997,205    — 
Net gain/(loss) on firm trading accounts   66,825    (111)
Other revenue   261,846    830,263 
TOTAL REVENUES   5,394,111    4,250,590 
           
EXPENSES          
Compensation, payroll taxes and benefits   2,718,784    3,123,630 
Data processing and clearing costs   1,897,046    584,250 
Regulatory, professional fees and related expenses   1,302,136    250,573 
Stock compensation expense   606,740    155,411 
Communications   195,547    218,869 
Occupancy and equipment   103,595    36,751 
Transfer fees   18,415    48,160 
Bank charges   60,570    58,718 
Bad debt   62,328    40 
Intangible assets amortization   355,795    355,795 
Other   592,717    295,631 
TOTAL EXPENSES   7,913,673    5,127,828 
           
LOSS FROM OPERATIONS   (2,519,562)   (877,238)
           
OTHER INCOME/(EXPENSE)          
Interest income   496,135    486,357 
Change in fair value of warrant liability derivative   344,380    (61,531)
Change in fair value of convertible note derivative   —    (52,873)
Change in fair value of long-term and short-term note derivative   —    103,185 
Change in fair value of secured convertible note   665,192    — 
Change in fair value of merger financing   —    63,696 
Change in fair value of earnout liability   249,000    (116,000)
Change in fair value of Winston & Strawn agreement   —    1,798,624 
Change in fair value of debenture derivative   (109,721)   (837,888)
Change in fair value of Tau agreement   —    334,549 
Interest expense   (401,713)   (1,434,210)
TOTAL OTHER INCOME/(EXPENSE)   1,243,273    283,909 
           
NET LOSS BEFORE INCOME TAXES   (1,276,289)   (593,329)
           
Income tax (expense) benefit   223,318   153,035 
           
NET LOSS  $(1,052,971)  $(440,294)
           
Basic weighted average shares outstanding, common stock   151,539,948    59,947,249 
Basic net loss per share, common stock  $(0.01)  $(0.01)
           
Diluted weighted average shares outstanding, common stock   151,539,948    59,947,249 
Diluted net loss per share, common stock  $(0.01)  $(0.01)

 

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

 

4
Table of Contents

 

ATLASCLEAR HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

(UNAUDITED)

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2026

 

   Shares   Amount   Receivable   Capital   Deficit   (Deficit) 
   Common Stock  

Stock

Subscription

   Additional Paid-in   Accumulated  

Total

Stockholders’ Equity

 
   Shares   Amount   Receivable   Capital   Deficit   (Deficit) 
Balance — June 30, 2026   150,337,774   $15,033   $(41,089)  $159,115,656   $(137,949,327)  $21,140,273 
                               
Shares issued to officers under stock based compensation   1,400,000    140    —    (140)   —    — 
                               
Vested portion of stock based compensation   —    —    —    606,740    —    606,740 
                               
Shares issued in non-cash exercise of Warrant Liability   100,970    10    —    18,468    —    18,478 
                               
Net loss   —    —    —    —    (1,052,971)   (1,052,971)
                               
Balance — September 30, 2026 (unaudited)   151,838,744   $15,183   $(41,089)  $159,740,724   $(139,002,298)  $20,712,520 

 

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2025

 

   Common Stock  

Stock

Subscription

  

Additional Paid-In

   Accumulated   Total Stockholders’ 
   Shares   Amount   Receivable   Capital   Deficit   Deficit 
Balance — June 30, 2025   40,165,603   $4,016   $(41,089)  $135,763,445   $(142,523,820)  $(6,797,448)
                               
Shares issued as conversion of $2,680,437 principal
And interest on long-term and merger financing notes
   15,922,008    1,592    —    2,678,845    —    2,680,437 
                               
Shares issued as conversion of $9,591,650 in principal and interest on secured convertible notes   63,944,332    6,394    —    9,585,256    —    9,591,650 
                               
Shares issued as conversion of $959,764 in principal on convertible notes Chardan   4,845,072    485    —    959,279    —    959,764 
                               
Shares issued under Software as a Service License Agreement   356,901    36    —    57,785    —    57,821 
                               
Shares issued as conversion of $438,922 in principal and interest on promissory notes   585,229    58    —    438,864    —    438,922 
                               
Shares issued for consulting services provided by director   800,000    80    —    169,840    —    169,920 
                               
Shares issued to settle vendor invoice   200,000    20    —    39,980    —    40,000 
                               
Vested portion of stock-based compensation   —    —    —    155,411    —    155,411 
                               
Net loss   —    —    —    —    (440,294)   (440,294)
                               
Balance — September 30, 2025 (unaudited)   126,819,145   $12,681   $(41,089)  $149,848,705   $(142,964,114)  $6,856,183 

 

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

 

5
Table of Contents

 

ATLASCLEAR HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

   2026   2025 
   Three Months Ended 
   September 30, 
   2026   2025 
Cash Flows from Operating Activities:          
Net income (loss)  $(1,052,971)  $     (440,294) 
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:          
Change in fair value, warrant liability derivative   (344,380)   61,531 
Change in fair value, convertible note derivative   —    52,873 
Change in fair value, long-term and short-term note derivative   —    (103,185)
Change in fair value, debenture derivative   109,721    837,888 
Change in fair value, secured convertible note   (665,192)   — 
Change in fair value, WDCO sellers convertible notes   —    (63,696)
Change in fair value, earnout liability   (249,000)   116,000 
Change in fair value, subscription agreement   —    (1,798,624)
Change in fair value, Tau agreement   —    (334,549)
Stock based compensation   606,740    155,411 
Consulting expense paid with stock   —    267,741 
Other non-cash (gain) loss   —    61,438 
Amortization of intangibles   355,795    355,795 
Bad debt expense   62,328    40 
Amortization of right to use asset   90,461    27,121 
Deferred tax liability   (235,068)   (160,986)
Non-cash interest in expense on financial instruments   344,825    1,342,569 
Changes in operating assets and liabilities:          
Receivables from brokers & dealers   2,467,410    (9,469,913)
Receivables from customers   (5,560,889)   (660,213)
Receivables from others   (45,429)   (1,294)
Advances & Prepaid expenses   168,935    230,526 
Cash deposits with clearing organization & other B/Ds   —    (750,000)
Other assets   (128,024)   (37,587)
Payables to customers   1,482,024    7,377,461 
Payables to officers & directors   (47,300)   153,448 
Payable to brokers & dealers   3,804    1,237,883 
Accounts payable and accrued expenses   (660,234)   (920,453)
Commissions and payroll taxes payable   (482,449)   (8,625)
Lease liability   (88,090)   (27,112)
Trading securities   (76)   (1,430)
Net cash (used for) operating activities   (3,867,059)   (2,500,236)

 

6
Table of Contents

 

ATLASCLEAR HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS CONTINUED

(UNAUDITED)

 

Cash Flows from Investing Activities        
Cash paid for purchase of Pacsquare   —    (65,000)
Net cash used for investing activities   —    (65,000)
           
Cash Flows from Financing Activities          
Proceeds from Convertible Notes, net of transaction cost   —    4,700,000 
Proceeds from debenture, net of transaction cost   —    490,000 
Proceeds from third party advance   —    200,000 
Repayment of promissory notes   (137,260)   (249,555)
Net cash provided by (used for) financing activities   (137,260)   5,140,445 
           
Net Change in Cash, Cash Equivalents and Restricted Cash   (4,004,319)   2,575,209 
           
Cash, cash equivalents and restricted cash at beginning of period   39,842,481    29,609,219 
           
Cash, cash equivalents and restricted cash  at end of period  $35,838,162   $32,184,428 
           
Supplementary cash flow information:          
           
Cash paid for interest  $37,345   $33,725 
Cash paid for income taxes  $—   $— 
           
Supplemental cash flow information non-cash investing and financing activities:          
           
Receivable from shares advanced under Tau agreement  $—   $205,238 
Shares issued for conversion on convertible notes Chardan  $—   $959,764 
Shares issued for conversion of secured convertible notes  $—   $9,591,650 
Shares issued for conversion of principal and interest on short-term note  $—   $1,014,055 
Shares issued for conversion of principal and interest on long-term note and merger financing  $—   $1,666,382 
Shares issued for conversion of principal and interest on promissory note   —    438,922 
Initial value of derivative included debenture  $—   $352,067 
Initial value of derivative included convertible note  $—   $382,154 
Original issued discount included in convertible note  $—   $1,000,000 
Shares issued under stock-based compensation awards  $

140

   $

—

 
Shares issued for non-cash exercise of Warrant Liability  $

18,478

   $

—

 

 

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

 

7
Table of Contents

 

ATLASCLEAR HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

 

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

 

AtlasClear Holdings, Inc. (formerly known as Calculator New Pubco, Inc.) (the “Company” or “AtlasClear Holdings”) is a Delaware corporation and, prior to the Business Combination (defined below), was a direct, wholly-owned subsidiary of Quantum FinTech Acquisition Corporation (“Quantum”). Quantum was incorporated in Delaware on October 1, 2020. Quantum was a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities.

 

On February 9, 2024 (the “Closing Date”), the Company consummated the previously announced transactions pursuant to that certain Business Combination Agreement dated November 16, 2022 (as amended, the “Business Combination Agreement”), among the Company, Quantum, AtlasClear, Inc. (“AtlasClear”), Atlas FinTech Holdings Corp. (“Atlas FinTech”) and certain other parties. The transactions consummated as a result of the Business Combination Agreement are hereinafter referred to as the “Business Combination.” In connection with the consummation of the Business Combination (the “Closing”), the Company changed its name from “Calculator New Pubco, Inc.” to “AtlasClear Holdings, Inc.” As a result, the operating history of Quantum survived the merger. Pursuant to the Business Combination Agreement, AtlasClear received certain assets from Atlas FinTech and Atlas Financial Technologies Corp., a Delaware corporation, and completed the acquisition of broker-dealer Wilson-Davis & Co., Inc., which changed its name to AtlasClearing, Inc. (“AtlasClearing”).  

 

On February 16, 2024, AtlasClear and Pacsquare Technologies, LLC (“Pacsquare”) entered into a Source Code Purchase and Master Services Agreement (the “Pacsquare Purchase Agreement”), pursuant to which AtlasClear purchased a proprietary trading platform with clearing and settlement capabilities that will be developed by Pacsquare, including certain software and source code (the “AtlasClear Platform”).

 

AtlasClear Holdings’ goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement and banking, with evolving and innovative financial products that focus on financial services firms. AtlasClear Holdings is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading.

 

AtlasClear does not meet the definition of a business and therefore was treated as an asset acquisition by AtlasClear Holdings. As such the assets contributed from Atlas FinTech and the net assets of AtlasClear were recognized at historical cost. ASC 350 prohibits the recognition of goodwill in an asset purchase with related parties.

 

Quantum was deemed the accounting acquirer based on the following factors: i) Quantum issued cash and shares of its common stock; ii) Quantum controlled the voting rights under the no redemption and the maximum contractual redemption scenarios; iii) Quantum had the largest minority voting interest; iv) Quantum has control over the board of directors of the post-combination company and most of senior management of the post-combination company are former officers of Quantum.

 

AtlasClearing is a securities broker and dealer, dealing in over-the-counter and listed securities and clears for one other broker-dealer on a fully disclosed basis. AtlasClearing is required to comply with all applicable rules and regulations of the Securities and Exchange Commission (the “SEC”), the Financial Industry Regulatory Authority, Inc. (“FINRA”), and the various securities exchanges in which it maintains a membership.

 

Revenue is derived principally from AtlasClearing’s operations in four areas: commission revenue, fee revenue, security locates and interest revenue.

 

AtlasClearing has operations in Utah, Arizona, California, Florida, New York, Oklahoma and Nevada. Transactions for customers are principally in the states where the Company operates, however, some customers are located in other states in which the Company is registered. Principal trading activities are conducted with other broker dealers throughout the United States.

 

8
Table of Contents

 

ATLASCLEAR HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

 

Liquidity and Going Concern Considerations

 

As of September 30, 2026, the Company had unrestricted cash and cash equivalents of $9.4 million and has experienced recurring operating losses and negative cash flows from operations since inception. During the three months ended September 30, 2026, and in the period immediately following the balance sheet date, the Company incurred significant cash outflows, including operating cash expenditures, a $2.5 million cash payment in October 2026 related to the Ark acquisition (see Note 15). In addition, additional cash commitments are expected for $2.44 million due at the Ark closing, and the Company has a $2.5 million seller note maturing in January 2027.

 

Management evaluated the Company’s liquidity position and continuous operational plans in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Subtopic 205-40, Presentation of Financial Statements – Going Concern. Management’s base cash flow forecast for the twelve months following the issuance date of these condensed consolidated financial statements indicates that projected operating cash flows and existing cash balances on hand may not be sufficient to satisfy all anticipated obligations as they become due.

 

However, management has evaluated probable and executable mitigation plans. Specifically, the Company has accessible capital resources that can be drawn down or completed to fully fund any potential cash flow deficits. While management does not anticipate requiring capital beyond baseline operational expectations, these funding mechanisms are available, and management believes them to be sufficient to absorb any liquidity shortfalls during the assessment period.

 

Based on the available capital resources and management’s operational and financial mitigation plans, management expects to have sufficient liquidity to satisfy its obligations as they become due for at least twelve months following the date these condensed consolidated financial statements are issued. Accordingly, management concluded that there is no substantial doubt about the Company’s ability to continue as a going concern.

 

9
Table of Contents

 

ATLASCLEAR HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

 

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

 

The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K, as filed with the SEC on September 24, 2026. The accompanying condensed balance sheet as of June 30, 2026 has been derived from the audited financial statements included in the Form 10-K. The interim results for the three months ended September 30, 2026 are not necessarily indicative of the results to be expected for the year ending June 30, 2027 or for any future periods.

 

Principles of Consolidation

 

The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

 

Use of Estimates

 

The preparation of the consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Prevailing industry practices requires management to make estimates and assumptions regarding trading securities, depreciation and other matters that affect certain reported amounts and disclosures in the financial statements. The more significant accounting estimates included in these consolidated financial statements are the determination of the fair value of the private warrant liabilities, the fair value of the warrant liability, the fair value of the derivatives included in the convertible notes and debenture agreement, the fair value of the secured convertible note, the merger financing, the short-term merger financing, the long-term merger financing, the fair value of the earnout liability, realization of deferred tax assets and the useful life of its intangible assets. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.

 

Cash and Cash Equivalents

 

The Company considers all bank accounts highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents.

 

Trading Securities

 

Securities held in the Company’s trading account and trading securities sold not yet purchased, consist primarily of over-the-counter securities and are valued based upon quoted market prices. The value of securities that are not readily marketable are estimated by management based upon quoted prices, the number of market makers, trading volume and number of shares held. Unrealized gains and losses are reflected in income in the financial statements.

 

Property and Equipment

 

Property and equipment are stated at cost less accumulated depreciation. Depreciation on property and equipment is provided using accelerated and straight-line methods over expected useful lives of three to seven years.

 

10
Table of Contents

 

ATLASCLEAR HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

 

Leases

 

The Company leases office space under the terms of several operating leases. The determination of whether an arrangement is a lease is made at the lease’s inception. Under ASC 842, a contract is (or contains) a lease if it conveys the right to control the use of an identified asset for a period of time in exchange for consideration. Control is defined under the standard as having both the right to obtain substantially all of the economic benefits from use of the asset and the right to direct the use of the asset. Management only reassesses its determination if the terms and conditions of the contract are changed.

 

Right-of-use assets (“ROU assets”) represent the Company’s right to use an underlying asset for the lease term, and lease liabilities represent the Company’s obligation to make lease payments. Operating lease ROU assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. The Company uses the implicit rate when it is readily determinable. Since the Company’s leases do not provide implicit rates, to determine the present value of lease payments, management uses the Company’s estimated incremental borrowing rate based on the information available at lease commencement.

 

Goodwill

 

Goodwill represents the excess of purchase price in a business combination over the fair value of the net identifiable assets acquired. The Company evaluates goodwill for impairment at the reporting unit level by assessing whether it is more likely than not that the fair value of a reporting unit exceeds its carrying value. If this assessment concludes that it is more likely than not that the fair value of a reporting unit exceeds its carrying value, then goodwill is not considered impaired and no further impairment testing is required. Conversely, if the assessment concludes that it is more likely than not that the fair value of a reporting unit is less than its carrying value, a goodwill impairment test is performed to compare the fair value of the reporting unit to its carrying value. The Company determines fair value of the reporting unit using income models. The models contain significant assumptions and accounting estimates about discount rates, future cash flows, that could materially affect operating results or financial position if they were to change significantly in the future and could result in an impairment. The Company performs its goodwill impairment assessment whenever events or changes in facts or circumstances indicate that impairment may exist and during the fourth fiscal quarter each year. The cash flow estimates and discount rates incorporate management’s best estimates, using appropriate and customary assumptions and projections at the date of evaluation. As of September 30, 2026 and June 30, 2026, the carrying value of goodwill was $6,142,525.

 

Intangible Assets

 

Intangible assets are presented at acquisition-date fair value, net of accumulated amortization. The fair value is determined based on the appraised value of the asset. Intangible assets comprise of developed technology and customer relationships (See Note 7). Developed technology and customer list are amortized using the straight-line method over the ten-year and twelve-year estimated useful lives of the assets, respectively. As of September 30, 2026 and June 30, 2026, the carrying value of developed technology was $1,543,674 and $1,592,277, respectively. The carrying value of customer list was $11,406,164 and $11,713,356, respectively.

 

Impairment of Long-lived and Intangible Assets

 

In accordance with ASC 360-10 Property Plant and Equipment and ASC 350-10 Intangibles, the Company, on a regular basis, reviews the carrying amount of long-lived assets for the existence of facts or circumstances, both internally and externally, that suggest impairment. The Company determines if the carrying amount of a long-lived asset is impaired based on anticipated undiscounted cash flows, before interest, from the use of the asset. In the event of impairment, a loss is recognized based on the amount by which the carrying amount exceeds the fair value of the asset. Fair value is determined based on the appraised value of the assets or the anticipated cash flows from the use of the asset, discounted at a rate commensurate with the risk involved. The Company had no impairment charges during the three-month periods ended September 30, 2026 and 2025.

 

Warrant Liabilities

 

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in FASB ASC 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

 

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants that do not meet all the criteria for equity classification are recognized as a non-cash gain or loss on the consolidated statements of operations. The fair value of the warrant liabilities were estimated using a Black-Scholes model approach (see Note 13).

 

11
Table of Contents

 

ATLASCLEAR HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

 

Income Taxes

 

The Company utilizes the asset and liability method to account for income taxes. The objective of this method is to establish deferred tax assets and liabilities for the temporary differences between net income for financial reporting basis and the tax basis of the Company’s assets and liabilities at enacted tax rates expected to be in effect when such amounts are realized.

 

Income tax expense or benefit is provided based upon the financial statement earnings of the Company. The allowance for doubtful accounts is deductible for financial statement purposes, but not for tax purposes. Depreciation expense is recognized in different periods for tax and financial accounting purposes due to the use of accelerated depreciation methods for income tax purposes. The tax effects of such differences are reported as deferred income taxes in the financial statements.

 

Revenue Recognition

 

AtlasClearing, a subsidiary of the Company, recognizes revenue in accordance with ASC 606. This revenue recognition guidance requires that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance requires an entity to follow a five-step model to: (a) identify the contract(s) with a customer, (b) identify the performance obligations in the contract, (c) determine the transaction price, (d) allocate the transaction price to the performance obligations in the contract, and (e) recognize revenue when the entity satisfies a performance obligation.

 

AtlasClearing acts as an agent by selling securities to customers and collecting commissions. AtlasClearing recognizes commissions on a trade date basis, which is the day the transaction is executed. AtlasClearing believes that the performance obligation is satisfied on the trade date because that is when the security is selected, the price is determined, the trade is executed, and the risks and rewards of ownership have been transferred to/from the customer.

 

AtlasClearing also receives commissions on mutual funds purchased by customers. AtlasClearing believes that the performance obligation is not satisfied until the mutual funds are purchased by customers and recognizes the commission revenue upon receipt from fund.

 

AtlasClearing performs vetting services to customers who wish to convert restricted stock to eligible trading stock. In addition, AtlasClearing charges clearing fees to another broker-dealer that it clears trades for. AtlasClearing recognizes revenue as the related performance obligations are satisfied.

 

AtlasClearing earns fees from providing security locates to other broker-dealers in connection with short sale transactions. The Company’s performance obligation is satisfied when the locate is provided to the requesting broker-dealer. Revenue from locate services is recognized at a point in time upon delivery of the locate, in an amount that reflects the consideration the Company expects to receive for the service provided.

 

AtlasClearing charges customers for wires and transfer agent fees. The customer is also charged for blue sheet fees, corporate actions, and ACATS fees. AtlasClearing recognizes revenue as the related performance obligations are satisfied.

 

AtlasClearing performs underwriting services for companies going public. AtlasClearing enters into an agreement detailing the services to be performed. AtlasClearing recognizes revenue when the shares of stock have been delivered and wire payments have been processed.

 

AtlasClearing earns interest on its balances with its financial institution. AtlasClearing recognizes the interest income at month end when the income has been earned.

 

Net Income (Loss) per Common Stock

 

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per share of common stock is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding for the period.

 

Diluted net income (loss) per share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding plus potential incremental common shares that would have been outstanding if dilutive potential common shares had been issued, calculated using the treasury stock method or the if-converted method, as applicable. Potential common shares are excluded from the computation of diluted net income (loss) per share if their effect would be antidilutive.

 

12
Table of Contents

 

ATLASCLEAR HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

 

For the three months ended September 30, 2026 and 2025, the Company was in a net loss position. As a result, basic and diluted net loss per share are identical for all periods presented, as the inclusion of any potentially dilutive securities would have an antidilutive effect on loss per share.

 

Specifically, for the three months ended September 30, 2026 and 2025:

 

Stock Options: Outstanding stock options (including options that were in-the-money based on average market price) were excluded from the computation of diluted net loss per share because the Company reported a net loss for the periods, rendering their inclusion antidilutive under the treasury stock method.

 

Convertible Notes and Debentures: The if-converted calculation for the secured convertible notes and debentures resulted in an adjusted net loss position; therefore, the effect of assuming conversion was antidilutive.

 

Stock Warrants: Outstanding stock warrants were excluded from the computation of diluted net loss per share as their exercise prices exceeded the average market price of the common stock during the respective periods, rendering them antidilutive.

 

The following table reflects the calculation of basic and diluted net income (loss) per share of common stock (in dollars, except share amounts):

  

   Three Months Ended   Three Months Ended 
   September 30, 2026   September 30, 2025 
Basic and diluted net (loss) income per common stock          
Numerator:          
Net (loss) income  $(1,052,971)  $(440,294)
Denominator:          
Basic and diluted weighted average common stock outstanding   151,539,948    59,947,249 
Basic and diluted net (loss) income per common stock  $(0.01)  $(0.01)

 

13
Table of Contents

 

ATLASCLEAR HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

 

Below is a summary of the potentially dilutive instruments as of September 30, 2026 and 2025:

  

Description  September 30, 2026   September 30, 2025 
Convertible Securities (if-Converted):          
Debenture   3,718,460    3,888,887 
Secured convertible note   14,961,176    670,307 
Subscription agreement   —    1,195,986 
Promissory note   —              576,616 
Total Convertible Securities Excluded   18,679,636    6,331,796 
           
Contingently issuable shares (Pending Performance Condition)          
Performance-Based (Market Condition) Stock Awards   18,979,843    15,852,395 
           
Stock Based Awards          
Time-Based Stock Awards   573,684    1,973,684 
In-the Money Stock Options   3,486,347    — 
Total Stock Based Awards– excluded   4,060,031    1,973,684 
           
Out-of-the Money Warrants:          
Public Warrants   10,062,500    10,062,500 
Private Warrants           5,553,125            5,553,125 
Secured convertible note warrants   600,000    600,000 
Warrant Liability   16,225,977    — 
Total Warrants excluded   32,441,602    16,215,625 

 

14
Table of Contents

 

ATLASCLEAR HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Deposit Insurance Coverage of $250,000. The Company has not experienced losses on these accounts. The Company’s cash is deposited at two financial institutions. At September 30, 2026, the Company had $34,313,456   in excess of the FDIC limit.

 

Fair Value of Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term nature, except for warrant liabilities, the debenture derivative liability, the secured convertible note (carried at fair value under the fair value option) and the earnout liability (see Note 13).

 

Derivative Financial Instruments

 

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC 815. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the issuance date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.

 

Segment Reporting

 

The Company operates and manages its business as a single operating and reportable segment in accordance with FASB ASC Topic 280, Segment Reporting. Operating segments are defined as components of an enterprise for which separate financial information is evaluated regularly by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources and assess performance. The Company’s CODM is the Executive Chairman, who reviews consolidated financial results, assets, and operational metrics to make decisions for the enterprise as a whole.

 

Risk Management

 

Transactions involving financial instruments involve varying degrees of market, credit and operating risk. The Company monitors its exposure to risk on a daily basis.

 

Market Risk

 

Market risk is the potential change in value of the financial instrument caused by unfavorable changes in interest rates and equity prices. Management is responsible for reviewing trading positions, exposure limits, profits and losses, and trading strategies. In the normal course of business, the Company purchases, and makes markets in non-investment grade securities. These activities expose the Company to a higher degree of market risk than is associated with investing or trading in investment grade instruments.

 

Operating Risk

 

Operating risk focuses on the Company’s ability to accumulate, process and communicate information necessary to conduct its daily operations. Deficiencies in technology, financial systems and controls and losses attributable to operational problems all pose potential operating risks. In order to mitigate these risks, the Company has established and maintains an internal control environment which incorporates various control mechanisms throughout the organization. In addition, the Company periodically monitors its technological needs and makes changes as deemed appropriate.

 

Credit Risk

 

AtlasClearing’s transactions with customers and other broker dealers are recorded on a trade date basis and are collateralized by the underlying securities. AtlasClearing’s exposure to credit risk associated with nonperformance by customers or contra brokers is impacted by volatile or illiquid trading markets. Should either the customers or other broker dealers fail to perform, AtlasClearing may be required to complete the transactions at prevailing market prices. AtlasClearing manages credit risk by monitoring net exposure to individual counterparties on a regular basis. Historically, reserve requirements arising from instruments with off-balance sheet risk have not been material. Receivables and payables with clearing and other broker dealers are generally collateralized by cash deposits. Additional cash deposits are requested when considered necessary by the clearing organization or contra broker dealer.

 

15
Table of Contents

 

ATLASCLEAR HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

 

Customer transactions are primarily entered in cash accounts. AtlasClearing maintains a few customer margin accounts which expose the company to credit and market risks. However, this risk is minimized by AtlasClearing requirement that margin accounts must maintain at least a 4:1 ratio of securities to margin obligations.

 

Concentrations of credit risk that arise from financial instruments (whether on or off-balance sheet) exist for groups of counterparties when they have similar economic characteristics that would cause their ability to meet obligations to be similarly affected by economic, industry or geographic factors.

 

Recent Accounting Standards

 

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”), which requires the Company to disclose specified additional information in its income tax rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. ASU 2023-09 will also require the Company to disaggregate its income taxes paid disclosure by federal, state and foreign taxes, with further disaggregation required for significant individual jurisdictions. ASU 2023-09 became effective for the Company for the annual period ended June 30, 2026. The adoption of ASU 2023-09 impacted the Company’s income tax disclosures only and did not have a material effect on the Company’s consolidated financial position, results of operations, or cash flows.

 

In November 2024, the FASB issued ASU 2024-04, Debt with Conversion and Other Options (Subtopic 470-20) Induced Conversions of Convertible Debt Instruments, a new standard to clarify the accounting for settlements of convertible debt instruments. The amendments clarify the criteria used to determine whether a settlement of convertible debt should be accounted for as an induced conversion (resulting in the recognition of an inducement expense) or as a debt extinguishment (resulting in a gain or loss on extinguishment). Specifically, the update clarifies that induced conversion accounting applies only if the inducement offer preserves the form and amount of consideration issuable under the instrument’s existing conversion privileges. It also extends the guidance to include convertible debt instruments containing cash conversion features and instruments that are not currently convertible at the offer date, provided they contain a substantive conversion feature. The Company adopted ASU 2024-04 effective July 1, 2026, the beginning of its fiscal year ending June 30, 2027. The adoption of this guidance did not have an impact on the Company’s condensed consolidated financial statements or its accounting treatment for its existing debt obligations.

 

Recent Issued Accounting Pronouncements Not Yet Adopted

 

In November 2024, the FASB issued ASU No. 2024-03, Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures, a new standard to expand disclosures about income statement expenses. The guidance requires disaggregation of certain costs and expenses included in each relevant expense caption on the income statements in a separate note to the financial statements at each interim and annual reporting period, including amounts of purchases of inventory, employee compensation, depreciation, and intangible asset amortization. The standard will be effective for annual periods beginning after December 15, 2026 (the Company’s fiscal year ending June 30, 2028), and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. We are currently evaluating the provision of this ASU.

 

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed consolidated financial statements.

 

NOTE 3. CASH SEGREGATED IN ACCORDANCE WITH FEDERAL REGULATIONS

 

AtlasClearing is required by Rule 15c3-3 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) to maintain a cash reserve with respect to customers’ transactions and credit balances, on a settlement date basis. Such a reserve is computed weekly using a formula provided by the rule and the reserve account must be separate from all other bank accounts of AtlasClearing. The required reserve as of September 30, 2026 and June 30, 2026, was calculated to be $21,258,771 and $22,436,492, respectively. AtlasClearing had $25,353,771 and $23,376,990, respectively, cash on deposit in the reserve account, which was $4,095,000 and $940,498 more than the amount required, respectively. On October 1, 2026, AtlasClearing withdrew $3,595,000 from the reserve account in accordance with the rule which resulted in an excess of $500,000. On July 1, 2026, AtlasClearing withdrew $400,000 from the reserve account in accordance with the rule which resulted in an excess of $540,498.

 

AtlasClearing is also required by Rule 15c3-3 of the Exchange Act to maintain a cash reserve with respect to broker-dealer transactions and credit balances. Such a reserve is computed weekly using a formula provided by the rule and the reserve account must be separate from all other bank accounts of AtlasClearing. The required reserve as of September 30, 2026 and June 30, 2026, was calculated to be $276,892 and $521,309, respectively. As of September 30, 2026 and June 30, 2026, AtlasClearing had $383,751 and $378,962, respectively, cash on deposit in the reserve account, which was $106,859 more than the amount required as of September 30, 2026 and $142,347 less than the amount required as of June 30, 2026. On October 1, 2026, the Company withdrew $6,859 from the reserve in accordance with the rule which resulted in an excess of $100,000. On July 1, 2026, the Company timely deposited $242,347 to the reserve account in accordance with the rule which resulted in an excess of $100,000.

 

16
Table of Contents

 

ATLASCLEAR HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

 

NOTE 4. NET CAPITAL REQUIREMENTS

 

As a broker dealer, AtlasClearing is subject to the uniform net capital rule adopted and administered by the SEC. The rule requires maintenance of minimum net capital and prohibits a broker dealer from engaging in securities transactions at a time when its net capital falls below minimum requirements, as those terms are defined by the rule. Under the alternative method permitted by this rule, net capital shall not be less than the greater of $250,000 or 2% of aggregate debit items arising from customer transactions, as defined. AtlasClearing also has a minimum requirement based upon the number of securities’ markets that the Company maintains. At September 30, 2026 and June 30, 2026, AtlasClearing’s net capital was $15,166,441 and $14,416,508, respectively, which was $14,916,441 and $14,166,508, respectively, in excess of the minimum required.

 

NOTE 5 – CASH AND RESTRICTED CASH

 

Reconciliation of cash and restricted cash as shown in the condensed statements of cash flows is presented in the table below:

  

   September 30, 2026   June 30, 2026 
Cash and cash equivalents  $9,431,777   $15,422,176 
Cash segregated - customers   25,353,770    23,376,990 
Cash segregated – FPL   668,864    

664,353

 
Cash segregated - PAB   383,751    378,962 
Total cash and restricted cash shown in the statement of cash flows.  $35,838,162   $39,842,481 

 

NOTE 6. - RECEIVABLES & PAYABLES WITH BROKER DEALERS AND CLEARING ORGANIZATION

 

Amounts receivable and payable with broker dealers and the clearing organization include:

  SCHEDULE OF AMOUNTS RECEIVABLE AND PAYABLE WITH BROKER DEALERS AND THE CLEARING ORGANIZATION

   September 30, 2026   June 30, 2026 
         
Due from clearing organizations, net  $1,044,551   $2,311,797 
Fails to deliver and receive   346,132    1,546,296 
Total receivables  $1,390,683   $3,858,093 
           
Due to clearing organizations, net  $—   $40 
Fails to deliver and receive   3,844    — 
Total payables  $3,844   $40 

 

No losses were recognized on the receivables from broker dealers or clearing organizations during the periods ended September 30, 2026 and 2025.

 

Accounts receivable from and payable to customers at September 30, 2026 and June 30, 2026, include cash and margin accounts. Securities owned by customers are held as collateral for any unpaid amounts. Such collateral is not reflected in the financial statements. The Company provides an allowance for credit losses, as needed, for accounts in which collection is uncertain. Management periodically evaluates each account on a case-by-case basis to determine impairment. Accounts that are deemed uncollectible are written off to bad debt expense. Bad debt expense net of bad debt recoveries and trading error adjustments for the periods ended September 30, 2026 and 2025 was $62,328 and $40, respectively.

 

17
Table of Contents

 

ATLASCLEAR HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

 

NOTE 7. INTANGIBLE ASSETS AND GOODWILL

 

Amortization expense related to the amortization of developed technology and customer list. During the periods ended September 30, 2026 and 2025 amortization expense of $355,795 and $355,795, respectively, was recognized.

 

Intangible Assets of the Company at September 30, 2026 and June 30, 2026 are summarized as follows:

  

      September 30, 2026 
   Est useful      Accumulated   Impairment     
   life  Cost   Amortization   of Asset   Net 
                    
Goodwill  Indefinite  $6,142,525   $—   $—   $6,142,525 
Developed technology  10 years   1,928,800    (385,126)   —    1,543,674 
Customer Lists  12 years   14,625,000    (3,218,836)   —    11,406,164 
Intangible Assets     $22,696,325   $(3,603,962)  $—   $19,092,363 

 

      June 30, 2026 
   Est useful      Accumulated   Impairment     
   life  Cost   Amortization   of Asset   Net 
                    
Goodwill  Indefinite  $6,142,525   $—   $—   $6,142,525 
Developed technology  10 years   1,928,800    (336,523)   —    1,592,277 
Customer Lists  12 years   14,625,000    (2,911,644)   —    11,713,356 
Intangible Assets     $22,696,325   $(3,248,167)  $—   $19,448,158 

 

Below is a summary of the amortization of intangible assets for the next five years:

  

Year  Amount 
Remainder of fiscal year ending June 30, 2027  $1,055,782 
June 30, 2028   1,415,445 
June 30, 2029   1,411,577 
June 30, 2030   1,411,577 
June 30, 2031   1,411,577 
Thereafter   6,243,880 

 

18
Table of Contents

 

ATLASCLEAR HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

 

NOTE 8. RELATED PARTY TRANSACTIONS

 

Advances from Related Parties

 

On May 9, 2024, Quantum Ventures, a related party, transferred 935 shares of Common Stock to pay for $47,750 of interest in connection with the Short-Term Notes that were payable to the sellers of AtlasClearing. The Company agreed to reimburse Quantum Ventures for the value of the shares plus 13% interest; as such a payable of $55,087 is due and payable to Quantum Ventures. This amount is reflected on the balance sheet as stock payable to related party as of September 30, 2026 and June 30, 2026.

 

As of September 30, 2026 and June 30, 2026, amounts due to Executive Chairman for advances made were $0 and $20,000. The amounts have been repaid as of September 30, 2026.

 

As of September 30, 2026 and June 30, 2026, amounts due to the President for advances made were $0 and $27,300, respectively. The amounts have been repaid as of September 30, 2026.

 

Note Financing

 

In September 2025, the Company entered into the September Securities Purchase Agreements, as defined and described in Note 9 below. $1,050,000 and $1,000,000, respectively, of the aggregate purchase price amount of the Convertible Notes sold pursuant to the September-Securities Purchase Agreements were sold to Sixth Borough Capital Fund, LP, an entity controlled by Robert D. Keyser, Jr., who is a member of the Company’s board of directors, and to Sandip Patel, the Company’s General Counsel, Chief Financial Officer and a member of the Company’s board of directors.

 

On October 8, 2025, the Company repaid the principal to Sandip Patel $1,200,000 in cash and to Sixth Borough Capital Fund, LP, $640,000 in cash and $500,000 through the issuance of Units sold pursuant to the Equity SPA (as defined in Note 9). As such, as of September 30, 2026 and June 30, 2026, no amounts are due under the Convertible Notes sold pursuant to the September Securities Purchase agreement held by Sandip Patel and Sixth Borough Capital Fund, LP.

 

Other related party transactions

 

On July 17, 2025, the Company issued 800,000 shares of Common Stock to Sandip I. Patel, P.A., a law firm that is wholly owned by Sandip I. Patel, the Company’s General Counsel, Chief Financial Officer and a member of the Company’s board of directors, as consideration for legal and consulting services provided to the Company prior to his employment. The shares were valued based on the closing price of the date of issuance of $0.2124  for a total value of $169,920.

 

Twelve subordinated loan agreements totaling $1,930,000 are with current and former shareholders and debt holders of AtlasClearing. $1,280,000 of the loans are no longer treated as related parties. Interest expense associated with the subordinated borrowings totaled $40,125 for the three months ended September 30, 2026 and $154,100 during the year ended June 30, 2026. As of September 30, 2026 and June 30, 2026 interest payable on the subordinated notes was $40,125 and $40,125, respectively.

 

Debenture

 

On August 4, 2025, the Company entered into a securities purchase agreement (“August Securities Purchase Agreement”) with an institutional investor (the “Holder”) controlled by Robert D. Keyser, Jr., a member of our board of directors, under which the Company agreed to issue and sell, in a private placement, a Series A convertible debentures (the “Debenture”) for an aggregate principal amount of $500,000, for a gross purchase price of $490,000, net of legal fees. The Debenture bears 10% interest and originally was to mature on August 3, 2026. On September 11, 2026, the Company and the Holder entered into an amendment to the Debenture, extending the maturity date to February 3, 2027, subject to accelerated repayment under certain circumstances. The Holder is entitled to convert the unpaid principal amount of the Debenture, plus accrued interest and penalties, at any time at $0.15 per share. If, at any time, the Company receives financing from third party (excluding the Holder), the Company is required to pay to the Holder, in the form of cash, equity, or a combination of the two, solely at the discretion of the Holder, one hundred percent (100%) of the proceeds raised from the third party until such time as the face amount of the Debenture has been paid in full. In the event all or any portion of this Debenture remains outstanding on the Maturity Date, the unconverted portion will automatically be converted into shares of Common Stock on such date.

 

The Holder is an entity controlled by Robert D. Keyser, Jr., a member of the Company’s board of directors. The amendment was accounted for as a modification.

 

19
Table of Contents

 

ATLASCLEAR HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

 

The Debenture is within the scope of ASC 470-10 and is not an ASC 480 liability. The Company did not elect the fair value option under ASC 825-10. The instrument contains two embedded derivatives—the conversion option and the event-of-default feature—each of which requires bifurcation and separate measurement at fair value through earnings. Other redemption and prepayment features are clearly and closely related and remain within the debt host. The Debenture is therefore recognized net of a debt discount, with the derivative liabilities recorded separately and subsequently remeasured to fair value through earnings. Interest expense will be recognized using the effective-interest method.

 

The Company recognized the discount of $362,067 at issuance consisting of the fair value of the derivative at issuance of $352,067, and $10,000 of transaction cost paid at closing. As a result, the Company recognized $30,172 in amortized debt discount and $11,936 in interest expense for the three months ended September 30, 2026. The Company recognized $60,345 in amortized debt discount and $8,333 in interest expense for the three months ended September 30, 2025. The balance as of September 30, 2026 is $557,769 net of $0 of unamortized debt discount. The balance as of June 30, 2026 is $515,661 net of $30,172 of unamortized debt discount. See note 13 for additional disclosure regarding fair value of the derivative.

 

NOTE 9. NOTES PAYABLE

 

The following table represents the notes payable and related financing as of September 30, 2026 and June 30, 2026: 

 

   September 30, 2026   June 30, 2026 
         
Promissory notes  $293,224   $430,484 
Debenture (related party)   557,769    515,661 
Subordinated borrowings   

1,930,000

    

—

 
Derivative liability - debenture   362,095    252,374 
Current portion  $3,143,088   $1,198,519 
           
Secured Convertible Note, net   10,847,883    11,210,358 
Subordinated borrowings   —    1,930,000 
Long term portion  $10,847,883   $13,140,358 

 

Chardan Convertible Note

 

During the three months ended September 30, 2025, the Company issued a total of 4,845,072 shares of Common Stock to Chardan Capital Markets LLC (“Chardan”) under a promissory note issued to Chardan on October 23, 2024 (the “Chardan Note”), for a total of $959,764 in principal. The conversion rate of 90% of the trailing seven-trading day VWAP prior to payment was between $0.16 and $0.18 per share. As a result, the Company recognized $240,897 in amortized debt discount included in interest expense and has fully settled the Chardan Note balance. As of September 30, 2026 and June 30, 2026, the balance under the Chardan Note was $0.

 

See Note 13 for additional information on the fair value and change in fair value related to the derivative.

 

Secured Convertible Note Financing

 

On October 8, 2025, the Company entered into an amended and restated securities purchase agreement (the “Restated SPA”) with Funicular Funds, LP (“Funicular”), which amended and restated in its entirety the securities purchase agreement, dated February 9, 2024, pursuant to which the Company had issued and sold to Funicular, in a private placement, a secured convertible note in the original principal amount of $6,000,000 (the “Funicular Note”). Pursuant to the Restated SPA, the Company issued and sold to Funicular, for a purchase price of $10,000,000, an amended and restated convertible promissory note, dated October 8, 2025 (the “Restated Note”), which amends and restates the Funicular Note in its entirety. The Restated Note represents a freestanding financial liability within the scope of ASC 470-10 Debt – Overall, with certain fair value election provisions applied under ASC 825-10 Financial Instruments – Overall. The Restated Note replaces the Funicular Note, increasing the principal balance from approximately $97,782 to $10,097,782, thereby constituting a significant new investment and creating an extinguishment of the prior note under ASC 470-50 Debt – Modifications and Extinguishments.

 

The Company elected to apply the Fair Value Option (FVO) under ASC 825-10 to the Restated Note. Under ASC 825-10-15-4 and 825-10-25-4, the Restated Note qualifies as an eligible financial liability because it is recognized upon initial issuance and not within any of the prohibited categories. The election was made at initial recognition and applies to the entire instrument, with upfront fees and costs expensed as incurred. As a result, the Restated Note is measured at fair value with changes recognized in earnings each reporting period consistent with ASC 825-10-45-5.

 

As part of the transaction, fees and expenses incurred in connection with the amendment—principally legal and negotiation costs up to $25,000 —were deducted from the proceeds of the note and treated as fees paid to the creditor under ASC 470-50-40-17. Because the Restated Note is accounted for under the fair value option, third-party costs are expensed as incurred in accordance with ASC 825-10-25-3.

 

20
Table of Contents

 

ATLASCLEAR HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

 

For the three months ended September 30, 2026, the Company recognized $302,717 in accumulated interest under the Restated Note and recognized a gain from the  change in the fair value of $665,192 for the three months ended September 30, 2026. For the three months ended September 30, 2025, the Company recognized $269,925 in interest expense on the principal and $513,201 of interest related to the amortization of the debt discount. As of September 30, 2025, the carrying value of the Funicular Note was $100,546, net of discount of $0. See Note 13 for additional information on the fair value and change in fair value related to the Funicular Note.

 

Promissory Notes

 

Pursuant to a convertible promissory note with Interest Solutions, LLC., dated as of February 9, 2024, in the aggregate principal amount of $275,000 (the “Interest Solutions Note”), accrued interest on the Interest Solutions Note is payable monthly, beginning on June 30, 2024, at a rate of 13% per annum and the Interest Solution Note matures on February 9, 2026. During the three months ended September 30, 2026 and 2025, the Company recognized $0 and $8,913, respectively, in interest expenses. September 30, 2026, not amounts are due under this note.

 

Pursuant to a convertible promissory note with JonesTrading Institutional Services LLC, dated as of February 9, 2024, in the aggregate principal amount of $375,000 (the “JonesTrading Note”), accrued interest on the JonesTrading Note is payable monthly, beginning on June 30, 2024, at a rate of 13% per annum. During the three-month period ended September 30, 2026 and 2025, the Company recognized $0 and $8,627 in interest expenses, respectively. As of September 30, 2026, not amounts are due under this note.

 

Hanire Purchase Agreement: During the year ended June 30, 2026, the Company received $200,000 as a good faith deposit towards the securities purchase agreement entered into on December 31, 2024 between the Company and Hanire, LLC (the “Hanire Purchase Agreement”). As such, the proceeds received are treated as due on demand non interest bearing advances. If terms of repayment and additional funding are not negotiated, the Company expects to refund the good faith deposit. As of September 30, 2026 and June 30, 2026, there was $200,000 and $200,000, respectively,   included in Promissory note payable.

 

D&O financing: During the year ended June 30, 2026, the Company renewed its Directors and Officers insurance policy and entered into a premium financing agreement to fund the annual premium which is included in Promissory note balance of $93,224 and $230,484 as of September 30, 2026 and June 30, 2026, respectively. The agreement requires nine equal monthly payments of $47,128 and provides for an interest rate of 8.75%, for total amount financed of $408,686. The unamortized portion of the insurance premium is recorded within “Prepaids” and is being amortized to “General and administrative expense” on a straight-line basis over the one-year policy term.

 

Equity Financing

 

On October 8, 2025, the Company entered into a securities purchase agreement (the “Equity SPA”) with certain institutional investors (each, an “Investor”), including Funicular, pursuant to which the Company agreed to issue and sell, in a private placement, 16,666,666 units of securities (each a “Unit”) for a purchase price of $0.60 per Unit. Each Unit consists of one share of the Common Stock and one warrant (each, a “Warrant Liability”) to purchase Common Stock. Due to rounding the units were split into 16,666,665 shares of Common Stock and 16,666,668 warrants. Of the total investment amount of $10,000,000, $5,850,000 of proceeds were received and $4,150,000 were converted from the Convertible Notes.

 

The Warrant Liability are immediately exercisable on a cash basis or exchangeable on a cashless basis and will expire five years from the date of issuance. Each Warrant Liability will be initially exercisable for one share of Common Stock at an initial exercise price of $0.75 per share, subject to adjustment for stock splits, distributions and the like (the “Initial Exercise Price”). The Initial Exercise Price is also subject to potential increase if the Company completes certain subsequent offerings at a price greater than the Initial Exercise Price while the Warrant Liability remain outstanding. At any time after the issuance of the Warrant Liability, the holder of the Warrant Liability may exchange the Warrant Liability on a cashless basis for a number of shares of Common Stock determined by multiplying the total number of shares with respect to which the Warrant Liability is then being exercised by the Black Scholes Value (as defined in the Warrant Liability) divided by the lower of the two closing bid prices of the Common Stock in the two days prior the time of such exercise.

 

In the event of a Fundamental Transaction (as defined in the Warrant Liability ), the holders of the Warrant Liability will be entitled to receive upon exercise of the Warrant Liability the kind and amount of securities, cash or other property that the holders would have received had they exercised the Warrant Liability immediately prior to such Fundamental Transaction. Additionally, as more fully described in the Warrant Liability , the holders of the Warrant Liability will be entitled to receive consideration in an amount equal to the Black Scholes value of the Warrant Liability in connection with a Fundamental Transaction. If the Company fails to timely deliver the shares of Common Stock issuable upon exercise of the Warrant Liability, the Company will be subject to liquidated damages.

 

Subject to the provisions of the Equity SPA, if, during the 12-month period commencing on the date of the closing, the Company carries out one or more Subsequent Financings (as defined in the Equity SPA), each Investor that purchases $50,000 or more of Units will have the right to participate in an amount up to 100% of such Investor’s investment amount under the Equity SPA in any such securities offered by the Company, subject to certain exceptions.

 

The Company engaged Dawson James Securities, Inc. as the placement agent (the “Placement Agent”) with respect to the offering of the Restated Note and the Units. The Company agreed to pay the Placement Agent’s fees totaling (i) 4.5% of the aggregate gross proceeds from the sale of the Restated Note, (ii) 6% of the aggregate gross proceeds from the sale of the Units to current or previous investors not introduced to the Company by the Placement Agent and (iii) 7% of the aggregate gross proceeds from the sale of the Units to investors introduced to the Company by the Placement Agent, and to reimburse the Placement Agent’s expenses (subject to a cap). Resulting in total transaction cost paid of $1,228,500. The Company also agreed to issue warrants to purchase up to an aggregate of 1,000,000 shares of Common Stock with a fair value of $334,062 to the Placement Agent and its designees, resulting in total transaction cost of $1,562,562. The fair value of the warrants issued to the Placement Agent was included in the transaction cost and allocated between the Warrant Liability in the amount of $865,659 and the Common Stock in the amount of $696,903 on a pro rated basis. Refer to note 11 for discussion regarding the cashless warrant exercised.

 

$500,000 of the Units sold pursuant to the Equity SPA were purchased by Sixth Borough Capital Fund, LP, an entity controlled by Robert D. Keyser, Jr., who is a member of the Company’s board of directors and the Chief Executive Officer of the Placement Agent.

 

21
Table of Contents

 

ATLASCLEAR HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

 

The closings of the issuance and sale of the Restated Note and the Units occurred on October 9th through October 14th, 2025, and the Company issued an aggregate of 16,666,665 shares of Common Stock and 16,666,668 Warrant Liability. Total proceeds were allocated between the warrants and the shares included in the units using the residual method with $5,540,000 fair value allocated to the warrant liability and $4,460,000 allocated to equity.

 

At the closings, the Company entered into a registration rights agreement with the Investors (the “Registration Rights Agreement”), pursuant to which the Company agreed, among other things, to file one or more registration statements covering the resale of the shares of Common Stock included as part of the Units, as well as the shares issuable upon conversion of the Restated Note or exercise of the Warrant Liability. The Company will be subject to liquidated damages if it fails to meet certain conditions set forth in the Registration Rights Agreement.

 

The Company evaluated the classification of the Warrant Liability, Common Stock, and the Registration Rights Agreement issued or entered into pursuant to the Equity SPA. The assessment was performed under the relevant guidance in ASC 480-10, ASC 815-10, ASC 815-40, and ASC 825-20, to determine whether these instruments should be accounted for as freestanding or embedded financial instruments, and whether they meet the criteria for equity or liability classification. The Warrant Liability is classified as freestanding derivative financial liabilities within the scope of ASC 815-10 and ASC 815-40, measured initially and subsequently at fair value through earnings. The issued shares of Common Stock are freestanding equity instruments. The Registration Rights Agreement is a freestanding contingent obligation within the scope of ASC 825-20, with potential liability recognition contingent on probability and estimability under ASC 450-20. See Note 13 for additional disclosure regarding fair value of the Warrant Liability.

 

Subordinated borrowings

 

The Company has entered into FINRA-approved subordinated loan agreements totaling $1,930,000. The agreements consist of (i) six legacy subordinated notes totaling $650,000 with current and former officers, directors, and related parties that bear interest at 5% per annum, and (ii) six subordinated loan agreements totaling $1,280,000 funded in October 2023. The October 2023 subordinated loans were renewed through amendments approved by FINRA and bear interest at 10% per annum, payable quarterly. The amended October 2023 subordinated notes mature in October 2026. Refer to Note 15 for further discussion.

 

The subordinated loan agreements generally mature annually and may be renewed upon agreement of the parties and approval by FINRA. Management currently anticipates that these borrowings will continue to be renewed as they mature; however, future renewals are subject to regulatory approval and the Company’s capital requirements.

 

The loan principal and related accrued interest are unsecured and subordinated in right of payment to all present and future creditors of the Company. The subordinated loans are allowable in the computation of net capital under Rule 15c3-1 of the Exchange Act. To the extent the subordinated borrowings are required for compliance with minimum net capital requirements, they may not be repaid without FINRA approval.

 

NOTE 10. COMMITMENTS AND CONTINGENCIES

 

Earnout Liability

 

In connection with the Closing, and pursuant to the terms of the Business Combination Agreement, stockholders of AtlasClear (the “AtlasClear Stockholders”) received merger consideration (the “Merger Consideration Shares”) consisting of 74,000 shares of Common Stock. In addition, the AtlasClear Stockholders were entitled to receive up to 5,944,444 shares of Common Stock (the “Earn Out Shares”) upon certain milestones (based on the achievement of certain price targets of Common Stock following the Closing). The milestones were not met during the first 18 months following the Closing, and as such the price target Earn Out Shares will not be issued. Atlas FinTech will also receive up to $20 million of shares of Common Stock (“Software Products Earn Out Shares”), which will be issued to Atlas FinTech upon certain milestones based on the achievement of certain revenue targets of software products contributed to AtlasClear by Atlas FinTech and Atlas Financial Technologies Corp. following the Closing. The revenue targets will be measured yearly for five years following the Closing, with no catch-up between the years. The earnout provision was analyzed under ASC 480 and ASC 815. The Software Products Earn Out Shares Payments are within the scope of ASC 480 and therefore have been accounted for as a liability.

 

As of September 30, 2026 and June 30, 2026, the fair value of the earnout liability was $14,000 and $263,000, respectively. As a result of the delay in the Company’s planned acquisition of Commercial Bancorp of Wyoming (“Commercial Bancorp”), the Company has not yet been able to implement the targets of software product revenue under the earnout. As such, management has revisited its revenue targets through the earnout period, resulting in a significant reduction in the estimated value attributed to the Software Product Earn Out Shares. See Note 13 Fair Value Measurements for additional information.

 

Employment Agreements

 

On September 19, 2025, the Company entered into employment agreements and amendments to employment agreements with each of John Schaible, the Company’s Executive Chairman, and Craig Ridenhour, the Company’s President, and on September 24, 2025, the Company entered into second amendments to such agreements with each such officer.

 

22
Table of Contents

 

ATLASCLEAR HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

 

The employment agreements with Mr. Schaible and Mr. Ridenhour, as amended by such amendments (as so amended, the “Schaible Employment Agreement” and the “Ridenhour Employment Agreement,” respectively) provide for the employment of Mr. Schaible and Mr. Ridenhour as Executive Chairman and President, respectively, reporting to the Board, for an initial term of three years, subject to automatic successive one-year renewals unless either party provides written notice of non-renewal at least 60 days’ prior to the end of the then-current term. Each executive is entitled to receive an initial annual base salary of $400,000, subject to review at least annually and increase to $450,000 and $500,000 in the second and third years of the term, respectively. In addition, each executive is entitled to receive (i) a one-time cash signing bonus of $300,000, of which one-third was payable immediately and the balance is payable upon the earlier of (a) a minimum qualified cumulative financing of $5 million or (b) one-third at the end of the fourth quarter of 2025 and one-third at the end of the first quarter of 2026; and (ii) one-time stock grants of 700,000 shares and 286,842 shares on signing and July 1, 2026, respectively, in each case to vest on June 30 of the year following the grant and subject to stockholder approval of an increase in the number of shares issuable under the equity incentive plan. Each executive is also entitled to receive an annual bonus, provided that the Company is profitable and determined at the discretion of the board, annual equity awards under the Company’s equity incentive plan, and up to five stock awards, each in an amount equal to 1% of the total number of the Company’s outstanding shares, vesting over three years, in the event the Company’s stock trading price reaches the following 10-day volume weighted average prices: $0.75, $1.00, $1.24, $1.49 and $1.74. On July 13, 2026 the 700,000 shares to each Mr. Schaible and Mr. Ridenhour were issued.

 

On September 24, 2025, the Company entered into an employment agreement with Sandip Patel (the “Patel Employment Agreement”), a member of the Board, pursuant to which Mr. Patel is employed as the Company’s General Counsel and Chief Financial Officer, reporting to the Board, for an initial term of three years, subject to automatic successive one-year renewals unless either party provides written notice of non-renewal at least 60 days’ prior to the end of the then-current term. Mr. Patel is entitled to receive an initial annual base salary of $350,000, subject to review at least annually and increase to $400,000 and $450,000 in the second and third years of the term, respectively. In addition, Mr. Patel is entitled to receive a one-time cash signing bonus of $250,000, of which one-third was payable immediately and the balance is payable upon the earlier of (a) a minimum qualified cumulative financing of $5 million or (b) one-third at the end of the fourth quarter of 2025 and one-third at the end of the first quarter of 2026. Mr. Patel is also entitled to receive an annual bonus, provided that the Company is profitable and determined at the discretion of the board, annual equity awards under the Company’s equity incentive plan, and up to five stock awards, each in an amount equal to 0.5% of the total number of the Company’s outstanding shares, vesting over three years, in the event the Company’s stock trading price reaches the following 10-day volume weighted average prices: $0.75, $1.00, $1.24, $1.49 and $1.74.

 

Refer to Note 12 for discussion regarding stock based compensation. As of June 30, 2026 the Company paid the one time signing bonuses for a total of $850,000 under the employment agreements discussed above.

 

Commercial Bancorp Share Purchase Agreement

 

On February 5, 2026, the Company entered into a share purchase agreement (the “Purchase Agreement”) with Commercial Bancorp, and each of the shareholders of Commercial Bancorp (collectively, the “Sellers”). The Purchase Agreement provides for the Company to acquire (the “CB Acquisition”) from the Sellers all of the outstanding shares (the “Shares”) of common stock of Commercial Bancorp, which is the owner of all of the outstanding stock of Farmers State Bank, a Wyoming state-chartered member bank (the “Bank”), subject to the terms and conditions set forth in the Purchase Agreement. As previously disclosed, the Company had previously entered into an agreement and plan of merger, as amended, to acquire Commercial Bancorp, which agreement has expired in accordance with its terms.

 

Pursuant to the terms of the Purchase Agreement, the Company has agreed to purchase the Shares from the Sellers for consideration consisting of a combination of cash and shares Common Stock, with the total amount of consideration to be determined based on (i) each Seller’s election to receive cash, shares of Common Stock, or a combination thereof, (ii) the adjusted book value of the operational portion of the equity capital of Commercial Bancorp as of the closing of the CB Acquisition (the “CB Closing”), determined in accordance with the provisions of the Purchase Agreement (the “ABV”), (iii) the value of the existing building and land comprising the physical location of the Bank (the “Premises”), and (iv) Commercial Bancorp’s net operating loss as reflected on its most recent tax return prior to the CB Closing, multiplied by the maximum corporate federal income tax rate in effect as of the date of the CB Closing (the “NOL Tax Benefit”). Each Seller may elect (the “Election”) to receive an amount equal to any of the following three options: (i) three times such Seller’s pro rata portion of the ABV, plus such Seller’s pro rata portion of the value of the Premises and the NOL Tax Benefit, payable one-third in cash and two-thirds in shares of Common Stock; (ii) two times such Seller’s pro rata portion of the ABV, plus such Seller’s pro rata portion of the value of the Premises and the NOL Tax Benefit, payable entirely in cash; or (iii) three times such Seller’s pro rata portion of the ABV, plus such Seller’s pro rata portion of the value of the Premises and the NOL Tax Benefit, payable entirely in shares of Common Stock. The Company has made an earnest money deposit payment in the amount of $100,000 to Commercial Bancorp, which deposit will be applied to the cash portion of the consideration payable at the CB Closing or, if the CB Closing does not occur under certain circumstances, retained by Commercial Bancorp.

 

The shares of Common Stock to be issued pursuant to the Purchase Agreement will be valued based on either the closing price of the Common Stock on the date of execution of the Purchase Agreement ($0.23), or on the business day immediately preceding the date of the CB Closing, at each Seller’s option. The Company agreed to file with the SEC, by the later of 90 days following the date of the Purchase Agreement and ten business days following the deadline for each Seller to make an Election, a resale registration statement with respect to the shares of Common Stock issuable pursuant to the Purchase Agreement (the “Resale Registration Statement”). The Resale Registration Statement was filed on June 8, 2026 and declared effective on June 17 , 2026.

 

23
Table of Contents

 

ATLASCLEAR HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

 

The obligations of each of the Sellers and the Company under the Purchase Agreement are subject to specified conditions, including, among other matters: (i) the receipt of all required regulatory approvals, (ii) the Resale Registration Statement having been declared effective by the SEC, such that all shares of Common Stock to be issued pursuant to the Purchase Agreement shall be registered for resale and freely tradeable, (iii) the receipt of certain specified third-party consents, and (iv) the absence of any injunctions being entered into or law being adopted that would make the CB Acquisition illegal.

 

The Purchase Agreement contains customary representations and warranties of Commercial Bancorp and the Bank, the Sellers and the Company. It also contains customary covenants, including (i) covenants providing for each of the parties to use reasonable best efforts to cause the CB Acquisition to be consummated and to receive all required regulatory approvals, including from the Federal Reserve Board and the Wyoming Division of Banking, (ii) covenants providing for Commercial Bancorp and the Bank to carry on their respective businesses in the ordinary course of business, and to refrain from taking certain actions, during the period between the execution of the Purchase Agreement and the CB Closing, and (iii) granting the Company observation rights with respect to meetings of the boards of directors of Commercial Bancorp and the Bank during the period between the execution of the Purchase Agreement and the CB Closing. Commercial Bancorp, the Bank and the Sellers have also agreed not to initiate, solicit, encourage or otherwise facilitate the making of any proposal or offer relating to alternate transactions or, engage in any discussions or negotiations with respect to alternate transactions.

 

The Purchase Agreement contains termination rights for each of the Sellers and the Company, including, without limitation, in the event that (i) any governmental entity issues a non-appealable final order denying approval of the CB Acquisition; (ii) the CB Acquisition is not consummated within two years of the execution of the Purchase Agreement, subject to extension under certain circumstances; or (iii) the other party breaches its representations, warranties or covenants under the Purchase Agreement which would give rise to the failure of a closing condition and such breach is not cured within 30-days of receipt of written notice of such breach.

 

Line of Credit

 

AtlasClearing has a $10,000,000 revolving line of credit with BMO Bank N.A. The interest rate is determined at the time of borrowing as agreed by the Company and the bank. The line of credit currently provides for interest at the bank’s overnight rate plus 1.5% and is secured by AtlasClearing’s assets. In addition, the line of credit carries an interest rate of 0.5% on its unused portion. The Company did not have an outstanding balance on the line of credit as of September 30, 2026 and June 30, 2026. The line of credit contains certain loan covenants and advances on the line of credit are payable on demand. Management believes the Company was in compliance with applicable covenants as of September 30, 2026 and June 30, 2026.

 

The line of credit agreement requires AtlasClearing to maintain line of credit collateral with value, as determined by the bank, in an amount at least equal to a percentage of the loan amount as specified by the bank. Advances on the line of credit are payable on demand. The entire amount of this credit facility is available to be drawn and used to meet AtlasClearing’s liquidity requirements for NSCC clearing margin deposits.

 

Indemnification Agreements

 

On the Closing Date, in connection with the Closing, the Company entered into indemnification agreements with each of its directors and executive officers, which provide for indemnification and advancements by the Company of certain expenses and costs under certain circumstances. The indemnification agreements provide that AtlasClear Holdings will indemnify each of its directors and executive officers against any and all expenses incurred by that director or executive officer because of his or her status as a director or officer of AtlasClear Holdings, to the fullest extent permitted by Delaware law, the Amended and Restated Certificate of Incorporation and the Amended and Restated Bylaws.

 

AtlasClearing

 

On February 27, 2018, an extended hearing panel of the Department of Enforcement of FINRA, Office of Hearing Officers, issued a decision ordering AtlasClearing to pay fines aggregating $1.47 million for violations of the applicable short sales and anti-money laundering rules. AtlasClearing appealed the decision to the National Adjudicatory Council (“NAC”). On December 19, 2019, NAC issued its decision ordering that the fines be reduced by $205,000 to an aggregate of $1.265 million. AtlasClearing made a timely appeal to the SEC to hear the case. On December 28, 2023, the SEC issued a ruling affirming the findings of violations and remanding the matter back to FINRA to reconsider the appropriate sanctions in light of the SEC decision. On July 10, 2025, the NAC reduced the fines to an aggregate of $490,000. The Company made a timely appeal of the decision to the SEC. Pursuant to FINRA Rules, the Company’s timely appeal of the decision to the SEC deferred the effectiveness of the findings and sanctions. Due to the disparity in the range of fines of similar cases, the Company believes that the final amount is not reasonably estimable. The Company has booked a contingent liability totaling $100,000 which represents the estimated low end of the possible range of fines.

 

Software Development and License agreement

 

On June 10, 2025, the Company and Pacsquare entered into a Software Development and License agreement, where the parties agreed to supersede and replace the Pacsquare Purchase Agreement and to fully release one another from any and all obligations or claims arising from or pursuant to the prior agreement. Therefore as a result of entering into the agreement the parties agreed to a 36 month term software development and licensing service where Pacsquare will continue to develop the Online Account Application (“OLA”) and will provide updates, bug fixes, patches or other error corrections and ongoing maintenance and support throughout the term of the agreement. Pacsquare will deliver the existing source code and provide up to 80 hours of developer-to developer support for knowledge transfer to new developers of the Company for a six month period. The OLA license shall be held by the Company perpetually, can be transferred and will be royalty free to modify and develop the platform for internal use or for white-label deployment, to charge correspondents a fee for use and transfer and assign such license in connection with the sale of AtlasClearing or the Company. Payment shall be $375,000 payable over the 36 month term as follows: $20,000 upon effective date of agreement, $15,000 first month payment and $10,000 for the remaining 34 months.

 

24
Table of Contents

 

ATLASCLEAR HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

 

NOTE 11. STOCKHOLDERS’ EQUITY (DEFICIT)

 

Preferred Stock — The Company is authorized to issue 25,000,000 shares of preferred stock with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At September 30, 2026 and June 30, 2026, there were no shares of preferred stock issued or outstanding.

 

Common stock — The Company is authorized to issue 500,000,000 shares of Common Stock with a par value of $0.0001 per share. Holders of the Company’s Common Stock are entitled to one vote for each share. At September 30, 2026 and June 30, 2026, there were 151,838,744 and 150,337,774 shares outstanding, respectively.

 

The Common Stock commenced trading on the NYSE American LLC (“NYSE American”) under the symbol “ATCH” on February 12, 2024. AtlasClear Holdings’ public warrants (the “Public Warrants”) commenced trading on the over-the-counter market (the “OTC”) under the symbol “ATCHW” on February 12, 2024.

 

Warrants—In connection with the Equity SPA, on October 8, 2025, the Company issued the Warrant Liability as discussed in Note 9 above. The warrants were issued to investors as an equity-linked incentive and to the placement agent as part of transaction compensation. The warrants entitle holders to purchase fully paid and non-assessable shares of common stock, subject to the terms summarized below.

 

Instruments Issued and Outstanding

 

  ● Investor Warrants: 16,666,668 warrants issued on October 8, 2025
     
  ● Placement Agent Warrants: 1,000,000 warrants issued on October 8, 2025
     
  ● Public Warrants: 10,062,500 warrants issued on February 9, 2024
     
  ● Private Warrants: 5,553,125 warrants issued on February 9, 2024
     
  ● Secured Convertible Note Warrants: 600,000 issued February 9, 2024
     
  ●

As of September 30, 2026 there are a total of 32,441,602 warrants outstanding. During the period ended September 30, 2026, the Company received two cashless warrant exercise notices from the Placement Agent Warrant holders, resulting in 27,358  warrants exercised and the issuance of 100,970 shares of Common Stock valued at $18,478.

 

As of June 30, 2026 there were a total of 32,468,960 warrants outstanding. During year ended June 30, 2026, the Company received three cashless warrant exercise notices from the Investor Warrant holders, resulting in 1,413,333 warrants exercised and the issuance of 4,214,127 shares of Common Stock valued at $1,094,669.

 

The warrants are freestanding financial instruments within the scope of ASC 815-10 and ASC 815-40. Although indexed to the Company’s own stock, the warrants do not qualify for equity classification because they contain provisions that could require net cash settlement (e.g., cash payout upon certain fundamental transactions and cash penalties for delayed share delivery). Accordingly, the warrants are classified as derivative financial liabilities and recorded at fair value on the balance sheet, with subsequent changes in fair value recognized in earnings.

 

Refer to Note 13 for discussion regarding the fair value disclosures.

 

The following is a roll forward of the warrants as of September 30, 2026 and June 30, 2026:

  

Warrant class  Beginning
Balance
June 30, 2026
   Issued   Exercised   Expired/Cancelled  

Ending

Balance

September 30, 2026

 
Investor warrants   15,253,335    —    —    —    15,253,335 
Placement Agent Warrants   1,000,000    —    (27,358)   —    972,642 
Public Warrants   10,062,500    —    —    —    10,062,500 
Private Warrants   5,553,125    —    —    —    5,553,125 
Secured Note Warrants   600,000    —    —    —    600,000 
Total   32,468,960    -     (27,358)   —    32,441,602 

 

25
Table of Contents

 

ATLASCLEAR HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

 

NOTE 12. STOCK BASED COMPENSATION

 

Plan Overview and Authorization

 

The Company grants stock options and restricted stock units to eligible employees, non-employee directors, and consultants pursuant to the 2024 Equity Incentive Plan (the “Plan”). On May 27, 2026, the Company amended the Plan to authorize 15,590,046 shares of common stock. Effective July 1, 2026, pursuant to the terms of the Plan, the number of authorized shares available for issuance automatically increased by 7,516,888 shares, bringing total authorized shares under the Plan to 23,106,934 shares.

 

As of September  30, 2026, there were 17,646,903 shares remaining available for grant under the Plan.

 

Summary of Award Groups and Terms

 

Group A and Group B (Stock Options)

 

Options granted under Groups A and B are fully vested as of the grant date. Group A options have a maximum contractual term expiring on January 26, 2030, and Group B options have a maximum contractual term expiring on June 30, 2031.

 

Group C and Group D (Restricted Stock / Equity Awards)

 

Group C awards are fully vested upon grant. Group D awards consist of 573,684 restricted shares subject to a continuous service vesting condition through June 30, 2027.

 

Accounting Policies and Valuation Methodology

 

Measurement and Recognition Policy

 

The Company measures stock-based compensation cost for equity instruments at fair value on the grant date. For award grants (Groups A, B, and C) authorized on May 27, 2026, for services rendered prior to June  30, 2026, where final grant approval and execution occurred on July 13 and July 14, 2026, compensation cost for the fiscal year ended June 30, 2026, was recognized based on the reporting-date fair value as of June 30, 2026, pursuant to ASC 718-10-35-6 and ASC 718-10-55-112. A cumulative catch-up adjustment to reflect the final grant-date fair values (July 13–14, 2026) was recognized in the first quarter of fiscal year 2027, resulting in a credit of $143,752.

 

Performance-Based (Market Condition) Stock Awards

 

Each of Messrs. Schaible and Ridenhour is eligible to receive up to five performance-based stock awards, each equal to 1% of the Company’s total outstanding shares at the time of grant, and Mr. Patel is eligible to receive up to five performance-based stock awards, each equal to 0.5% of the Company’s total outstanding shares, upon achievement of specified stock price milestones, in each case subject to stockholder approval of an amendment to the Company’s equity incentive plan to increase the number of shares authorized for issuance thereunder.

 

These milestones are based on the Company’s common stock achieving a 10-day volume-weighted average price (“VWAP”) of $0.75, $1.00, $1.24, $1.49, and $1.74, respectively. Each award vests over three years following achievement of the applicable stock price target, subject to continued employment.

 

Compensation cost for these awards will be recognized over the derived service period, regardless of whether the market condition is ultimately achieved, provided the requisite service is rendered.

 

As of September 30, 2026, none of the stock price milestones had been achieved and no shares had vested under the performance-based awards.

 

Forfeiture Policy

 

The Company accounts for forfeitures of share-based awards as they occur. Previously recognized compensation cost is reversed in the period an unvested award is forfeited.

 

Valuation Assumptions

 

The fair value of restricted stock is determined using the unadjusted closing market price of the Company’s common stock on the grant date. The fair value of stock options is estimated using the Black-Scholes option-pricing model.

 

The significant assumptions utilized to estimate the fair value of stock options granted during the periods presented were as follows:

 

Assumption (Group A and Group B) 

July

2026 Grants

 
Share Price  $0.179 
Exercise Price  $0.180 
Valuation Date   July 14, 2026 
Expected volatility   191.05%
Risk-free interest rate   4.31%
Expected term   5.0 years 
Expected dividend yield   0%

 

26
Table of Contents

 

ATLASCLEAR HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

 

Stock Option Activity and Roll-Forward

 

The following table summarizes stock option activity for the periods presented:

 

Option Roll-Forward  Number of Options  

Weighted-Average

Exercise Price

   Weighted-Average Remaining Contractual Term (Years)  

Aggregate

Intrinsic Value ($)

 
Granted (Group A & B)   3,486,347   $0.18    4.67      
Exercised   —                 
Forfeited/Expired   —                 
Outstanding at September 30, 2026   3,486,347   $0.18    4.67   $71,470 
Exercisable as of September 30, 2026 (Group A & B)   3,486,347   $0.18    4.67   $71,470 
Total             —      

 

Nonvested Restricted Share Activity

 

The following table summarizes nonvested restricted share activity for the periods presented:

 

Nonvested Share Roll-Forward      Weighted-Average 
   Number of Shares   Grant-Date Fair value 
Granted (Group C & D) – July 13, 2026   1,973,684   $0.173 
Vested (Group C)   (1,400,000)  $0.173 
Forfeited   —   $— 
Nonvested at September 30, 2026 (Group D)   573,684   $0.173 

 

As of September 30, 2026, total unrecognized compensation cost related to nonvested Group D restricted shares was approximately $74,436, which is expected to be recognized over a remaining weighted-average service period of 0.75 years (through June 30, 2027).

 

Stock-Based Compensation Expense

 

As of September 30, 2026, none of the stock price milestones had been achieved and no shares had vested under the performance-based awards.

 

Stock-based compensation expense recognized in the consolidated statements of operations was as follows:

 

SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE

   Three months ended   Three months ended 
   September 30, 2026   September 30, 2025 
Time-based stock awards  $(143,752)  $53,492 
Market-based stock awards  $750,492   $101,919 
Total stock-based compensation expense  $606,740   $155,411 

 

NOTE 13. FAIR VALUE MEASUREMENTS

 

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

 

  ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
  ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
  ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

 

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

 

The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at September 30, 2026 and June 30, 2026, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

 

SCHEDULE OF FAIR VALUE HIERARCHY OF THE VALUATION INPUTS

       September 30,   June 30, 
Description  Level   2026   2026 
Assets:               
Trading securities   1   $76   $— 
                
Liabilities:               
Warrant liability – Private Warrants   3   $110,757   $184,588 
Earnout liability   3   $14,000   $263,000 
Debenture – derivative   3   $362,095              $252,374 
Secured Convertible Note   3   $10,847,883   $11,210,358 
Warrants liability – Equity SPA   3   $2,724,340   $3,013,367 

 

27
Table of Contents

 

ATLASCLEAR HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

 

Warrant Liability

 

The private placement warrants originally issued by Quantum and assumed by the Company in connection with the Business Combination (the “Private Warrants”) were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liability in the consolidated statements of operations.

 

The Private Warrants were, initially and as of the end of each subsequent reporting period, valued using a lattice model, specifically a Black-Scholes model, which is considered to be a Level 3 fair value measurement. The primary unobservable input utilized in determining the fair value of the Private Warrants is the expected volatility of the Company’s Common Stock. The expected volatility of the Company’s Common Stock was determined based on the implied volatility of the publicly traded Public Warrants.

 

The key inputs into the Black-Scholes model for the Private Warrants were as follows:

SCHEDULE OF FAIR VALUE MEASUREMENT INPUTS AND VALUATION

Input  September 30, 2026   June 30, 2026 
Market price of public shares  $0.20   $0.20 
Risk-free rate   4.92%   4.15%
Dividend yield   0.00%   0.00%
Volatility   199.7%   205.12%
Exercise price  $689.86   $689.86 
           
Effective expiration date   February 2029    February 2029 

 

Earnout Liability

 

The liability associated with the Earnout Shares was, initially as of February 9, 2024, valued using a Monte Carlo simulation to determine if and when the revenue hurdles would be achieved. The revenue volatility and revenue to equity correlation was based upon the same guideline public companies. As of June 30, 2026, the Company revised when revenue hurdles would be achieved, as a result of the delay in financing and implementation of the Commercial Bancorp acquisition. Revenue targets were deemed less likely to be reached and as such, this resulted in a significant decrease in the value of the Earnout liability. The Monte Carlo simulation was performed simultaneously on both the share price and revenue to account for the correlation between revenue and equity.

 

The key inputs into the Monte Carlo model for the Earnout liability were as follows:

 

 

Input  September 30, 2026   June 30, 2026 
Market price of public shares  $0.20   $0.20 
Revenue volatility   50.00%   50.00%
Discount factor for revenue   21.74%   22.32%

 

 

28
Table of Contents

 

ATLASCLEAR HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

 

Secured Convertible Note

 

On October 8, 2025, the Company entered into the Restated SPA with Funicular. The Restated Note issued pursuant to the Restated SPA is convertible, in whole or in part, into shares of the Company’s Common Stock at the election of the holder at any time at an initial Conversion price of $0.75 per share. The Conversion Price is subject to adjustment if the Company issues or is deemed to issue shares of Common Stock at a price below the then-current Conversion Price (subject to certain exceptions), and is subject to customary adjustments for stock dividends, stock splits, reclassifications and the like. The Company elected to apply the Fair Value Option (FVO) under ASC 825-10 to the Restated Note. Under ASC 825-10-15-4 and 825-10-25-4, the Restated Note qualifies as an eligible financial liability because it is recognized upon initial issuance and not within any of the prohibited categories. The election was made at initial recognition and applies to the entire instrument, with upfront fees and costs expensed as incurred. As a result, the Restated Note is measured at fair value with changes recognized in earnings each reporting period consistent with ASC 825-10-45-5.

 

As of September 30, 2026 and June 30, 2026, the Restated Note was valued using Black-Scholes model combined with the discounted cash flow model, resulting in the fair value of the Restated Note of $10,847,883 and $11,210,358, respectively.

 

The key inputs into the Black-Scholes model for the conversion derivative as of September 30, 2026 and June 30, 2026 were as follows:

 

Input  September 30, 2026   June 30, 2026 
Market price of public shares  $0.20   $0.20 
Conversion Price  $0.75   $0.75 
Principal and interest balance at valuation date  $11,220,883   $10,918,165 
Risk-free rate   5.05%   4.18%
Discount rate   19.85%   17.95%
Volatility   164.98%   205.12%
Effective expiration date   October 2030    October 2030 
Term   4.02 years    4.28 years 

 

29
Table of Contents

 

ATLASCLEAR HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

 

Debenture Derivative

 

On August 4, 2025 the Company issued the Debenture as discussed in Note 8. The Company determined that the conversion feature was required to be bifurcated under ASC 815 and, as such, the Company fair valued the embedded derivative. As of September  30, 2026 the Debenture was valued using a Black-Scholes model and as of August 4, 2025, the issuance date, the Debenture was valued using a Scenario Based Methodology model resulting in the fair value of the conversion option included in the Debenture embedded derivative of $362,095 and $352,067, respectively. See Note 8 for additional information.

 

The key inputs into the Black-Scholes for the conversion derivative as of September 30, 2026 and June 30, 2026 were as follows:

 

Input  September 30, 2026   June 30, 2026 
Market price of public shares  $0.20   $0.20 
Risk-free rate   4.250%   3.71%
Discount rate   21.94%   20.06%
Volatility   164.980%   205.12%
Effective expiration date   February 2027    August 2026 

 

30
Table of Contents

 

ATLASCLEAR HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

 

Warrant Liability- Equity SPA

 

On October 8, 2025, the Company entered into the Equity SPA pursuant to which the Company agreed to issue and sell, in a private placement, 16,666,666 Units for a purchase price of $0.60 per Unit. Each Unit consists of one share of the Company’s Common Stock and one Warrant Liability. Due to rounding the units were split into 16,666,665 shares of Common Stock and 16,666,668 warrants. In addition, 1,000,000 of Warrant Liability was issued to the Placement Agent as transaction fees. The Warrant Liability was accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liability in the consolidated statements of operations. The fair value of all Warrant Liability issued at issuance was $5,874,061 ($5,539,999 for the warrants included in the units and $334,062 for the warrants issued to Placement Agent).

 

The Warrant Liability was, initially and as of the end of each subsequent reporting period, valued using a lattice model, specifically a Black-Scholes model, which is considered to be a Level 3 fair value measurement. The primary unobservable input utilized in determining the fair value of the Warrant Liability is the expected volatility of the Company’s Common Stock.

 

The key inputs into the Black-Scholes model for the Warrant Liability was as follows:

 

Input  September 30, 2026   June 30, 2026 
Market price of public shares  $0.20   $0.20 
Risk-free rate   5.05%   4.18%
Dividend yield   0.00%   0.00%
Volatility   164.98%   205.125%
Exercise price  $0.75   $0.75 
Term    4.02 years    4.27 years 
           
Effective expiration date   October 2030    October 2030 

 

 

The following table presents the changes in the fair value of the following:

  SCHEDULE OF CHANGES IN THE FAIR VALUE

   Private Placement   Earnout 
   Warrants   Liability 
Fair value as of June 30, 2026  $184,588   $263,000 
Change in valuation inputs or other assumptions   (73,831)   (249,000)
Fair value as of September 30, 2026  $110,757   $14,000 

 

   Private Placement   Tau Agreement 
   Warrants   Liability 
Fair value as of June 30, 2025  $123,062   $539,787 
Write off receivable   —    (205,238)
Change in valuation inputs or other assumptions   61,531    (334,549)
Fair value as of September 30, 2025  $184,593   $— 

 

31
Table of Contents

 

ATLASCLEAR HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

 

 

   Conversion   Earnout 
   Derivative   Liability 
Fair value as of June 30, 2025  $103,185   $11,369,000 
Change in valuation inputs or other assumptions   (103,185)   116,000 
Fair value as of September 30, 2025  $—   $11,485,000 

 

   Winston & Strawn   Merger Financing 
   Agreement   Derivative 
Fair value as of June 30, 2025  $2,489,945   $63,696 
Change in valuation inputs or other assumptions   (1,798,624)   (63,696)
Fair value liability as of September 30, 2025  $691,321   $— 

 

   Debenture 
   Derivative 
Fair value as of June 30, 2026  $252,374 
Change in valuation inputs or other assumptions   109,721 
Fair value as of September 30, 2026  $362,095 

 

   Debenture   Convertible Notes 
   Derivative   Derivative 
Fair value as of June 30, 2025  $—   $— 
Initial measurement   352,067    382,154 
Change in valuation inputs or other assumptions   837,888    52,873 
Fair value as of September 30, 2025  $1,189,955   $435,027 

 

  

Secured

Convertible Note

  

Warrant

Liability

 
Fair value as of June 30, 2026  $11,210,358   $3,013,367 
Accrued interest through September 30, 2026   302,717    — 
Fair value of warrants exercised        (18,478)
Change in valuation inputs or other assumptions   (665,192)   (270,549)
Fair value as of September 30, 2026  $10,847,883   $2,724,340 

 

There were no transfers between levels during three month periods ended September 30, 2026 and 2025.

 

32
Table of Contents

 

ATLASCLEAR HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

 

NOTE 14. SEGMENT REPORTING

 

The Company operates as one reportable segment in accordance with ASC 280, Segment Reporting. The single reportable segment reflects the Company’s core business operations of acting as securities broker and dealer, dealing in over-the-counter and listed securities.

 

The Chief Operating Decision Maker (CODM), identified as the Executive Chairman, reviews financial performance and allocates resources on a consolidated basis. The Company’s internal reporting is prepared and reviewed as a single operating unit, without disaggregated information by product line, region, or customer type. Accordingly, the Company has determined that it operates in a single reportable segment.

 

The following table presents revenue and operating income (loss) for the periods presented:

 

SCHEDULE OF REVENUE AND OPERATING INCOME LOSS

   Three months ended   Three months ended 
   September 30, 2026   September 30, 2025 
Commissions  $1,736,434   $2,334,389 
Vetting fees   230,015    371,700 
Clearing fees   101,786    714,349 
Stock locate fees   2,997,205    — 
Net gain/(loss) on firm trading accounts   66,825    (111)
Other revenue   261,846    830,263 
Total revenue  $5,394,111   $4,250,590 
Compensation, payroll taxes and benefits   2,718,784    3,123,630 
Data processing and clearing costs   1,897,046    584,250 
Regulatory, professional fees and related expenses   1,302,136    250,573 
Stock compensation expense   606,740    155,411 
Communications   195,547    218,869 
Occupancy and equipment   103,595    36,751 
Transfer fees   18,415    48,160 
Bank charges   60,570    58,718 
Bad debt   62,328    40 
Intangible assets amortization   355,795    355,795 
Other   592,717    295,631 
TOTAL EXPENSES   7,913,673    5,127,828 
Loss from operations  $(2,519,562)  $(877,238)
Total assets  $69,813,853   $73,634,759 

 

Corporate general and administrative expenses are not allocated to any specific operating component and are included within total operating income.

 

Segment Assets

 

The Company does not report separate asset information by segment to the CODM. However, in accordance with ASC 280-10-50-30, the Company has elected to disclose total segment assets, which are equal to consolidated total assets. The table above summarizes total assets.

 

NOTE 15. SUBSEQUENT EVENTS

 

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed consolidated financial statements were issued. Based upon this review the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed consolidated financial statements, other than as described below.

 

33
Table of Contents

 

ATLASCLEAR HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026

(Unaudited)

 

Business Combination Agreement with Ark Financial Services, Inc.

 

On October 14, 2026 (the “Signing Date”), the Company entered into a Business Combination Agreement (the “Acquisition Agreement”) with Ark Financial Services, Inc., a Delaware corporation (“Ark”), AC Ark Subco 1, Inc. (“Merger Sub”), AC Ark Subco 2, LLC (“Merger Sub II”), The Robert D. Keyser, Jr. Revocable Trust (the “Trust”), and Robert D. Keyser, Jr., as trustee and individual. Ark is the sole owner of Dawson James Securities, Inc., an investment bank and registered broker-dealer. Robert D. Keyser, Jr. is an officer and director of Ark and a member of the Board of Directors of the Company, and the Acquisition Agreement is therefore a related party transaction.

 

Pursuant to the terms of the Acquisition Agreement on the Signing Date, the Company acquired a 24.9% issued and outstanding equity interest in Ark from the Trust (the “Initial Equity Purchase”) for total consideration of $5,000,000, consisting of $2,500,000 in cash; and a promissory note issued to the Trust in the principal amount of $2,500,000 (the “Seller Note”). The Seller Note bears interest at 5.0% per annum and matures on the earliest of (i) 90 days from the Signing Date, (ii) the closing of a Qualified Financing (as defined in the Seller Note), or (iii) the Closing (as defined below). Also pursuant to the terms of the Acquisition Agreement, subject to regulatory approvals and other closing conditions, the Company will acquire the remaining 75.1% equity interest in Ark at a second closing (the “Closing”) through a merger of Merger Sub with and into Ark, immediately followed by a merger of the surviving entity with and into Merger Sub II. At the Closing, the consideration payable for the remaining equity securities of Ark will consist of $2,437,500 in cash; and a number of shares of Common Stock, calculated as $13,812,500 divided by the five-day volume-weighted average price (“VWAP”) of the Common Stock ending on the date of the Closing. In addition, the Company may pay up to an additional $812,500 in cash and $2,437,500 in Common Stock (valued using average VWAP of the Common Stock immediately prior to issuance) contingent upon Ark and its subsidiaries achieving annual revenue exceeding $21,250,000 in fiscal years ending December 31, 2026 and 2027 (payable up to 50% per year).

 

A portion of the cash and stock consideration payable at Closing will be placed in escrow for up to 18 months post-Closing to secure indemnification obligations. In connection with the agreement, the Company and the Trust executed a Registration Rights and Lock-Up Agreement, which becomes effective at Closing and will subject the shares issued to a six-month lock-up period and provides customary registration rights.

 

The Closing is subject to specified closing conditions, including required regulatory approvals (including FINRA approval) and, if required under NYSE American listing rules, approval by the Company’s stockholders. The Acquisition Agreement contains customary representations, warranties, covenants, and termination provisions.

 

The Company is currently evaluating the accounting treatment for the Initial Equity Purchase and the overall business combination under applicable U.S. GAAP guidance, including ASC 805, Business Combinations, ASC 323, Investments – Equity Method and Joint Ventures, and ASC 480 / ASC 815 regarding the classification and measurement of the consideration components, embedded terms, and contingent/deferred consideration structures. Because the initial transaction occurred subsequent to the balance sheet date of September 30, 2026, and the valuation and accounting analyses remain in process, the initial accounting for the transaction, including the allocation of purchase price and determination of control/significant influence during the interim period, has not been finalized as of the date these financial statements were issued.

 

October 2026 Grants

 

On October 1, 2026, the Company granted 5,692,065 stock options (representing 3.79% of the 150,337,774 total common shares outstanding as of June 30, 2026) with an exercise price of $0.201 per share. Across all 33 awards granted on October 1, 2026, total awards granted represented 8.00% of outstanding common shares. The estimated total fair value of the October 2026 grants (Group E) is to be determined, and will be recognized as compensation expense over the three-year vesting period beginning in fiscal year 2027. In addition, 6,338,877 stock options with en exercise price of $0.201 per share we granted on October 1, 2026, (Group F). The Group F awards differ from the Group E awards only in the identity and capacity of the grantees: three of them (626,881 options each, 1,880,643 in total) were granted to Thomas Hammond, Steven Carlson and Robert D. Keyser, Jr., the nonemployee directors who constitute the Committee, and one (777,332 options) to Sandip I. Patel, Chief Financial Officer and General Counsel.

 

Options granted under Group E and Group F vest over a three-year graded vesting schedule (one-third on each of October 1, 2027, October 1, 2028, and October 1, 2029, subject to continued service through each applicable vesting date), with a seven-year maximum contractual term expiring on October 1, 2033. Group E option awards are subject to single-trigger accelerated vesting upon a Change in Control pursuant to Section 9 of the Plan. The Company accounts for graded vesting awards using the straight-line attribution method under ASC 718-10-35-8.

 

October 2026 Subordinated Loan Maturity

 

Subsequent to September 30, 2026, four subordinated loan agreements with aggregate principal of $780,000 matured and were repaid, together with the related accrued interest. Two subordinated loan agreements, each with principal of $250,000, were renewed. Following these transactions, the Company had $1,150,000 of subordinated borrowings outstanding.

 

NYSE American Delisting

 

On November 10, 2026, the Company received notice from NYSE Regulation of the NYSE American LLC (“NYSE American”) that it had suspended trading of the Company’s Common Stock and determined to commence proceedings to delist the Company’s Common Stock from the NYSE American as a result of its determination that the Company is no longer suitable for listing pursuant to Section 1003(f)(v) of the NYSE American Company Guide due to the low selling price of the Company’s Common Stock.

 

The Company has a right to a review of NYSE American’s determination to delist the Company’s Common Stock by the Listings Qualifications Panel of the Committee for Review of the Board of Directors of the NYSE American, and the Company intends to request such a review; however, there can be no assurance that any such appeal will be successful. The NYSE American notice states that it will apply to the SEC to delist the Company’s Common Stock pending completion of applicable procedures, including any appeal by the Company of its determination.

 

The Company’s Common Stock began trading on the OTC Pink Limited Market on November 11, 2026.

 

34
Table of Contents

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

References in this quarterly report on Form 10-Q (the “Quarterly Report”) to “we,” “us,” “AtlasClear Holdings,” or the “Company” refer to AtlasClear Holdings, Inc. References to our “management” or our “management team” refer to our officers and directors. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties. Certain defined terms used herein have the meaning ascribed to them in the notes to the financial statements.

 

Special Note Regarding Forward-Looking Statements

 

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Quarterly Report including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy, plans and objectives of management for future operations, including the expected completion of the acquisitions of Commercial Bancorp of Wyomin, (“Commercial Bancorp”) and Ark Financial Services, Inc. (“Ark”), are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements.

 

Forward-looking statements are not guarantees of performance, and the absence of these words does not mean that a statement is not forward looking. You should understand that the following important factors could affect our future results, and could cause those results or other outcomes to differ materially from those expressed or implied in the forward-looking statements herein:

 

  ● the ability to maintain the listing of our Common Stock on the NYSE American LLC (“NYSE American”), including regaining compliance with the listing standards of the NYSE American, and the potential liquidity and trading of our Common Stock;
  ● our ability to realize the benefits expected from the Business Combination (as defined herein);
  ● our ability to obtain the required regulatory approvals for, and to complete, the acquisitions of Commercial Bancorp and Ark;
  ● our ability to successfully integrate our proposed acquisitions, including the planned acquisitions of Commercial Bancorp and Ark, and to realize the synergies and benefits of such acquisitions;
  ● our ability to successfully implement the AtlasClear Platform (as defined herein);
  ● our significant indebtedness and our ability to service such indebtedness;
  ● the volatility of the price of our common stock, par value $0.0001 per share (the “Common Stock”) and the possibility that stockholders could incur substantial losses;
  ● potential dilution of our stockholder interests resulting from our issuance of equity securities;
  ● our ability to grow and manage growth profitably;
  ● our ability to raise financing in the future, if and when needed;
  ● our success in retaining or recruiting, or adapting to changes in, our officers, key employees, or directors following the Business Combination;
  ● our ability to attract and retain our senior management and other highly qualified personnel;
  ● our ability to achieve or maintain profitability;
  ● the period over which we anticipate our existing cash and cash equivalents will be sufficient to fund our operating expenses and capital expenditure requirements;
  ● our ability to successfully protect against cybersecurity attacks or breaches, ransomware attacks, and other disruptions to our information technology structure;
  ● our ability to successfully compete against other companies;
  ● our estimates regarding expenses, future revenue, and needs for additional financing; and
  ● the effect of economic downturns and political and market conditions beyond our control.

 

For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s Annual Report on Form 10-K for the year ended June 30, 2026 (the “Annual Report”) filed with the U.S. Securities and Exchange Commission (the “SEC”) on September 24, 2026. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

 

Overview

 

Our goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement and banking, with evolving and innovative financial products that focus on financial services firms. We are a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, underwriting and trading. We believe we are positioned to provide a modern, mission-critical suite of solutions to our clients, enabling them to reduce their transactions costs and compete more effectively in their businesses.

 

Our target client base for our prime banking and prime brokerage services includes financial services firms, generally with annual revenues up to $1 billion, including brokerage firms, hedge funds, pension plans, and family offices that are not adequately served by today’s larger correspondent clearing firms and banks.

 

Through our subsidiary AtlasClearing, Inc. (formerly Wilson-Davis & Co) (“AtlasClearing”), a correspondent clearing company, and the anticipated acquisition of Commercial Bancorp, we provide specialized clearing and banking services to financial services firms, with an emphasis on global markets currently underserviced by larger vendors. Once properly integrated, anticipated synergies between Commercial Bancorp, if acquired, and AtlasClearing are expected to allow for lower cost of capital, higher net interest margins, expanded product development and greater credit extension.

 

35
Table of Contents

 

AtlasClearing

 

AtlasClearing is a correspondent securities broker-dealer registered with the SEC, licensed in 50 states, District of Columbia, and Puerto Rico, and is a member in good standing of the Financial Industry Regulatory Authority, Inc. (“FINRA”). AtlasClearing derives revenue principally from commissions charged on the liquidation of restricted and control microcap securities, vetting, and clearing service fees charged to introducing brokers for which AtlasClearing clears transactions on a fully disclosed basis, stock locate fees charged to other broker-dealers,  and other financial service fees. Commissions are earned by executing transactions for customers. Vetting fee revenues are earned when AtlasClearing vets stock the customers want to bring into their accounts. Clearing fees are earned by clearing transactions for Glendale Securities, as introducing broker on a fully disclosed basis, pursuant to a clearing agreement with Glendale Securities.

 

Key Factors Impacting AtlasClearing’s Business

 

AtlasClearing’s business and results of operations have been, and will continue to be, affected by numerous factors and trends, which AtlasClearing believes include the following and those discussed in the section titled “Risk Factors” of the Annual Report.

 

○Liquidity. As a clearing broker-dealer in the U.S., AtlasClearing is subject to cash deposit requirements with clearing organizations, brokers, and banks that may be large in relation to its total liquid assets.
○Growth of Customer Base. AtlasClearing’s growth requires continued use of its services by new customers.
○Expanding AtlasClearing’s Relationship with Existing Customers. AtlasClearing’s ability to expand its relationship with its existing customers will be an important contributor to its long-term growth.
○Market Trends. As financial markets grow and contract, AtlasClearing’s customers’ behaviors are affected. AtlasClearing’s revenue and profitability can be affected by general downturns in the securities markets, resulting from factors such as increased inflation, increased interest rates and other factors.

 

Commercial Bancorp Share Purchase Agreement

 

On February 5, 2026, the Company entered into a share purchase agreement (the “Purchase Agreement”) with Commercial Bancorp, and each of the shareholders of Commercial Bancorp (collectively, the “Sellers”). The Purchase Agreement provides for the Company to acquire (the “CB Acquisition”) from the Sellers all of the outstanding shares (the “Shares”) of common stock of Commercial Bancorp, which is the owner of all of the outstanding stock of Farmers State Bank, a Wyoming state-chartered member bank (the “Bank”), subject to the terms and conditions set forth in the Purchase Agreement. As previously disclosed, the Company had previously entered into an agreement and plan of merger, as amended, to acquire Commercial Bancorp, which agreement has expired in accordance with its terms.

 

Pursuant to the terms of the Purchase Agreement, the Company has agreed to purchase the Shares from the Sellers for consideration consisting of a combination of cash and shares of Common Stock, with the total amount of consideration to be determined based on (i) each Seller’s election to receive cash, shares of Common Stock, or a combination thereof, (ii) the adjusted book value of the operational portion of the equity capital of Commercial Bancorp as of the closing of the CB Acquisition (the “CB Closing”), determined in accordance with the provisions of the Purchase Agreement (the “ABV”), (iii) the value of the existing building and land comprising the physical location of the Bank (the “Premises”), and (iv) Commercial Bancorp’s net operating loss as reflected on its most recent tax return prior to the CB Closing, multiplied by the maximum corporate federal income tax rate in effect as of the date of the CB Closing (the “NOL Tax Benefit”). Each Seller may elect (the “Election”) to receive an amount equal to any of the following three options: (i) three times such Seller’s pro rata portion of the ABV, plus such Seller’s pro rata portion of the value of the Premises and the NOL Tax Benefit, payable one-third in cash and two-thirds in shares of Common Stock; (ii) two times such Seller’s pro rata portion of the ABV, plus such Seller’s pro rata portion of the value of the Premises and the NOL Tax Benefit, payable entirely in cash; or (iii) three times such Seller’s pro rata portion of the ABV, plus such Seller’s pro rata portion of the value of the Premises and the NOL Tax Benefit, payable entirely in shares of Common Stock. The Company has made an earnest money deposit payment in the amount of $100,000 to Commercial Bancorp, which deposit will be applied to the cash portion of the consideration payable at the CB Closing or, if the CB Closing does not occur under certain circumstances, retained by Commercial Bancorp.

 

The shares of Common Stock to be issued pursuant to the Purchase Agreement will be valued based on either the closing price of the Common Stock on the date of execution of the Purchase Agreement ($0.23), or on the business day immediately preceding the date of the CB Closing, at each Seller’s option. The Company agreed to file with the Securities Exchange Commission (the “SEC”) a resale registration statement with respect to the shares of Common Stock issuable pursuant to the Purchase Agreement (the “Resale Registration Statement”), which was filed on June 8, 2026.

 

The obligations of each of the Sellers and the Company under the Purchase Agreement are subject to specified conditions, including, among other matters: (i) the receipt of all required regulatory approvals, (ii) the Resale Registration Statement having been declared effective by the SEC, such that all shares of Common Stock to be issued pursuant to the Purchase Agreement shall be registered for resale and freely tradeable (which occurred on June 17, 2026), (iii) the receipt of certain specified third-party consents, and (iv) the absence of any injunctions being entered into or law being adopted that would make the CB Acquisition illegal.

 

The Purchase Agreement contains customary representations and warranties of Commercial Bancorp and the Bank, the Sellers and the Company. It also contains customary covenants, including (i) covenants providing for each of the parties to use reasonable best efforts to cause the CB Acquisition to be consummated and to receive all required regulatory approvals, including from the Federal Reserve Board and the Wyoming Division of Banking, (ii) covenants providing for Commercial Bancorp and the Bank to carry on their respective businesses in the ordinary course of business, and to refrain from taking certain actions, during the period between the execution of the Purchase Agreement and the CB Closing, and (iii) granting the Company observation rights with respect to meetings of the boards of directors of Commercial Bancorp and the Bank during the period between the execution of the Purchase Agreement and the CB Closing. Commercial Bancorp, the Bank and the Sellers have also agreed not to initiate, solicit, encourage or otherwise facilitate the making of any proposal or offer relating to alternate transactions or, engage in any discussions or negotiations with respect to alternate transactions.

 

The Purchase Agreement contains termination rights for each of the Sellers and the Company, including, without limitation, in the event that (i) any governmental entity issues a non-appealable final order denying approval of the CB Acquisition; (ii) the CB Acquisition is not consummated within two years of the execution of the Purchase Agreement, subject to extension under certain circumstances; or (iii) the other party breaches its representations, warranties or covenants under the Purchase Agreement which would give rise to the failure of a closing condition and such breach is not cured within 30-days of receipt of written notice of such breach.

 

Ark

 

On October 14, 2026 (the “Signing Date”), the Company entered into a business combination agreement (the “Acquisition Agreement”) with Ark Financial Services, Inc., a Delaware corporation (“Ark”), AC Ark Subco 1, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company (“Merger Sub”), AC Ark Subco 2, LLC, a Delaware limited liability company and a wholly-owned subsidiary of the Company (“Merger Sub II” and together with Merger Sub, the “Merger Subs”), The Robert D. Keyser, Jr. Revocable Trust, a Florida revocable trust and the majority stockholder of Ark (the “Trust”), and Robert D. Keyser, Jr., an individual. Ark is the sole owner of Dawson James Securities, Inc. (“Dawson James”), an investment bank and registered broker-dealer. Robert D. Keyser, Jr., the trustee of the Trust, is also an officer and director of Ark and a director of the Company. Pursuant to the terms of the Acquisition Agreement, on the Signing Date the Company purchased 24.9% of the issued and outstanding equity securities of Ark from the Trust (the “Initial Equity Purchase”), and the Company will, subject to the satisfaction of certain conditions, acquire the remaining equity securities of Ark at a subsequent closing (the “Closing”) by means of the merger of Merger Sub with and into Ark, immediately followed by the merger of the surviving company with and into Merger Sub II.

 

36
Table of Contents

 

The purchase price for the Initial Equity Purchase on the Signing Date consisted of $2,500,000 in cash and the issuance to the Trust of a promissory note in the original principal amount of $2,500,000 (the “Seller Note”). The Seller Note bears interest at the rate of 5% per annum and is payable in full on the earliest to occur of 90 days from the Signing Date, the date of the closing of a Qualified Financing (as defined in the Seller Note), and the Closing. Pursuant to the terms of the Acquisition Agreement, the purchase price payable by the Company at the Closing for the remaining equity securities of Ark will consist of $2,437,500 in cash and a number of shares of the Company’s common stock (“Common Stock”) calculated as $13,812,500 divided by the average volume weighted average price (“VWAP”) of the Common Stock over the five trading day period ending on the date of the Closing. In addition, the Company may pay up to an additional $812,500 in cash and a number of additional shares of Common Stock calculated as $2,437,500 divided by the average VWAP of the Common Stock immediately prior to issuance (collectively, the “Deferred Consideration”) based on the revenue of Ark and its subsidiaries exceeding $21,250,000 in the years ending December 31, 2026 and 2027 (with up to 50% of the Deferred Consideration payable on account of each such year). A portion of the cash and shares of Common Stock payable at Closing is to be held in an escrow account for up to 18 months following the Closing as security for the Company’s indemnification rights under the Acquisition Agreement.

 

The obligations of each of the parties under the Acquisition Agreement are subject to specified conditions, including, among other things: (i) the receipt of all required regulatory approvals, including the consent of FINRA, (ii) the Company’s stockholders having approved the issuance of the shares of Common Stock pursuant to the Acquisition Agreement, if such stockholder approval is required pursuant to the listing rules of the NYSE American (the “Company Stockholder Approval”), (iii) the absence of any material adverse effect with respect to the other parties, and (iv) the absence of any injunctions being entered into or law being adopted that would make the consummation of the transactions at the Closing illegal.

 

The Acquisition Agreement contains customary representations and warranties of the parties. It also contains customary covenants, including (i) covenants providing for each of the parties to use best efforts to satisfy all conditions to Closing, (ii) covenants providing for Ark to carry on its business in the ordinary course of business, and to refrain from taking certain actions, during the period between the Signing Date and the Closing, and (iii) covenants regarding efforts to obtain all required regulatory approvals and the Company Stockholder Approval. Ark and the Trust have also agreed not to solicit, initiate, induce, encourage or otherwise facilitate the making of any proposal or offer relating to alternate transactions or, engage in any discussions or negotiations with respect to certain alternate transactions.

 

The Acquisition Agreement contains termination rights for each of Ark and the Company, including, without limitation, in the event that (i) any governmental entity issues a non-appealable final order denying approval of the transactions contemplated by the Acquisition Agreement; (ii) the Closing does not occur within one year of the Signing Date; or (iii) the other party breaches its representations, warranties or covenants under the Acquisition Agreement which would give rise to the failure of a closing condition and such breach is not cured within 30 days of receipt of written notice of such breach.

 

Also on the Signing Date and in connection with the execution of the Acquisition Agreement, the Company and the Trust entered into a registration rights and lock-up agreement (the “RRA”), which will become effective at the Closing. Pursuant to the terms of the RRA, the Company granted the Trust certain registration rights with respect to the shares of Common Stock issuable pursuant to the terms of the Acquisition Agreement, and the Trust agreed not to transfer any of such shares for a period of six months following the Closing, subject to certain exceptions. Among other things, the Company agreed to file a resale shelf registration statement within six months following the Closing.

 

Debenture

 

On August 4, 2025, the Company entered into a securities purchase agreement with an institutional investor (the “Holder”) controlled by Robert D. Keyser, Jr., a member of our board of directors, under which the Company agreed to issue and sell, in a private placement, Series A convertible debentures (the “Debenture”) for an aggregate principal amount of $500,000, for a gross purchase price of $490,000, net of legal fees. The Debenture bears 10% interest and originally was to mature on August 3, 2026. On September 11, 2026, the maturity date was extended to February 3, 2027, subject to accelerated repayment under certain circumstances. The holder is entitled to convert the unpaid principal amount of the Debenture, plus accrued interest and penalties, any time, at $0.15 per share. If, at any time prior to maturity, the Company receives financing from a third party (excluding the Holder), the Company is required to pay to the Holder, in the form of cash, equity, or a combination of the two, solely at the discretion of the Holder, 100% of the proceeds raised from the third party until such time as the face amount of the Debenture has been paid in full. The Company also agreed (to file with the “SEC”) (at the Company’s sole cost and expense) a registration statement, or an amendment to a previously-filed registration statement registering the resale of the shares of Common Stock underlying the Debenture.

 

Convertible Note Financing

 

On October 8, 2025, the Company entered into an amended and restated securities purchase agreement (the “Restated SPA”) with Funicular Funds, LP (“Funicular”), which amended and restated in its entirety the securities purchase agreement, dated February 9, 2024, pursuant to which the Company had issued and sold to Funicular, in a private placement, a secured convertible note in the original principal amount of $6,000,000 (the “Funicular Note”). Pursuant to the Restated SPA, the Company issued and sold to Funicular, for a purchase price of $10,000,000, an amended and restated convertible promissory note, dated October 8, 2025 (the “Restated Note”), which amends and restates the Funicular Note in its entirety. The principal amount of the Restated Note is $10,097,782, consisting of the $10,000,000 purchase price plus $97,782 in remaining outstanding principal under the Funicular Note.

 

37
Table of Contents

 

The Restated Note has a stated maturity date of October 8, 2030. Interest accrues at a rate per annum equal to 11%, and is payable semi-annually on each June 30 and December 31. On each interest payment date, the accrued and unpaid interest shall, at the election of the Company in its sole discretion, be either paid in cash or paid in-kind by increasing the principal amount of the Restated Note. In the event of an Event of Default (as defined in the Restated Note), in addition to Funicular’s other rights and remedies, the interest rate would increase to 14% per annum. The Restated Note is convertible, in whole or in part, into shares of the Company’s common stock at the election of the holder at any time at an initial conversion price of $0.75 per share (the “Conversion Price”). The Conversion Price is subject to adjustment if the Company issues or is deemed to issue shares of common stock at a price below the then-current conversion price (subject to certain exceptions), and is subject to customary adjustments for stock dividends, stock splits, reclassifications and the like. The Restated Note contains covenants which, among other things, limit the ability of the Company and its subsidiaries to incur additional indebtedness, incur additional liens and sell its assets or properties.

 

The Restated Note is secured by a perfected security interest in substantially all of the existing and future assets of the Company and each Grantor (as defined in the Security Agreement, as defined below), including a pledge of all of the capital stock of each of the Grantors, subject to certain exceptions, as evidenced by (i) the security agreement, dated as of February 9, 2024 (the “Security Agreement”), among the Company, each of the Company’s subsidiaries and Funicular, and (ii) the guaranty, dated as of February 9, 2024 (the “Guaranty”), executed by each of the Company’s subsidiaries pursuant to which each of them has agreed to guaranty the obligations of the Company under the Restated Note and the other Loan Documents (as defined in the Restated Note), each of which was entered into in connection with the Funicular Note.

 

Pursuant to the Restated SPA, the Company agreed, among other things, that if the Restated Note becomes convertible into a number of shares of common stock in excess of 19.9% of the Company’s total number of shares of common stock outstanding, to seek the approval of its stockholders for the issuance of all shares of common stock issuable upon conversion of the Restated Note in excess of that amount, in accordance with the rules of the NYSE American.

 

Equity Financing

 

On October 8, 2025, the Company entered into a securities purchase agreement (the “Equity SPA”) with certain institutional investors (each, an “Investor”), including Funicular, pursuant to which the Company agreed to issue and sell, in a private placement, an aggregate of 16,666,666 units of securities (each, a “Unit”), for a purchase price of $0.60 per Unit. Each Unit consists of one share of the Company’s common stock and one warrant (each, a “2025 Warrant”) to purchase common stock.

 

The 2025 Warrants are immediately exercisable on a cash basis or exchangeable on a cashless basis and will expire five years from the date of issuance. Each 2025 Warrant will be initially exercisable for one share of common stock at an initial exercise price of $0.75 per share, subject to adjustment for stock splits, distributions and the like (the “Initial Exercise Price”). The Initial Exercise Price is also subject to potential increase if the Company completes certain subsequent offerings at a price greater than the Initial Exercise Price while the 2025 Warrants remain outstanding. At any time after the issuance of the 2025 Warrants, the holder of a 2025 Warrants may exchange the 2025 Warrants on a cashless basis for a number of shares of common stock determined by multiplying the total number of shares with respect to which the 2025 Warrant is then being exercised by the Black Scholes Value (as defined in the 2025 Warrant) divided by the lower of the two closing bid prices of the common stock in the two days prior the time of such exercise.

 

In the event of a Fundamental Transaction (as defined in the 2025 Warrants), the holders of the 2025 Warrants will be entitled to receive upon exercise of the 2025 Warrants the kind and amount of securities, cash or other property that the holders would have received had they exercised the 2025 Warrants immediately prior to such Fundamental Transaction. Additionally, as more fully described in the 2025 Warrants, the holders of the 2025 Warrants will be entitled to receive consideration in an amount equal to the Black Scholes value of the 2025 Warrant in connection with a Fundamental Transaction. If the Company fails to timely deliver the shares of common stock issuable upon exercise of the 2025 Warrants, the Company will be subject to liquidated damages.

 

Subject to the provisions of the Equity SPA, if, during the 12-month period commencing on the date of the closing, the Company carries out one or more Subsequent Financings (as defined in the Equity SPA), each Investor that purchases $50,000 or more of Units will have the right to participate in an amount up to 100% of such Investor’s investment amount under the Equity SPA in any such securities offered by the Company, subject to certain exceptions.

 

The Company engaged Dawson James Securities, Inc. as the placement agent (the “Placement Agent”) with respect to the offering of the Restated Note and the Units. The Company agreed to pay the Placement Agent’s fees totaling (i) 4.5% of the aggregate gross proceeds from the sale of the Restated Note, (ii) 6% of the aggregate gross proceeds from the sale of the Units to current or previous investors not introduced to the Company by the Placement Agent and (iii) 7% of the aggregate gross proceeds from the sale of the Units to investors introduced to the Company by the Placement Agent, and to reimburse the Placement Agent’s expenses (subject to a cap). The Company also agreed to issue certain warrants to the Placement Agent and its designees.

 

$500,000 of the Units sold pursuant to the Equity SPA were purchased by Sixth Borough Capital Fund, LP, an entity controlled by Robert D. Keyser, Jr., who is a member of the Company’s board of directors and the Chief Executive Officer of the Placement Agent.

 

The closings of the issuance and sale of the Restated Note and the Units occurred on October 9 through October 14, 2025.

 

At the closings, the Company entered into a registration rights agreement with the Investors (the “Registration Rights Agreement”), pursuant to which the Company agreed, among other things, to file one or more registration statements covering the resale of the shares of common stock included as part of the Units, as well as the shares issuable upon conversion of the Restated Note or exercise of the Warrants. The Company will be subject to liquidated damages if it fails to meet certain conditions set forth in the Registration Rights Agreement.

 

38
Table of Contents

 

Results of Operations

 

Comparison of the Three Months Ended September 30, 2026 Compared to the Three Months Ended September 30, 2025

 

   Three Months Ended   Three Months 
   September 30,   Ended 
   2026   2025   Changes 
             
REVENUES               
Commissions  $1,736,434   $2,334,389    (597,955)
Vetting fees   230,015    371,700    (141,685)
Clearing fees   101,786    714,349    (612,563)
Stock locate fees   2,997,205    —    2,997,205 
Net gain/(loss) on firm trading accounts   66,825    (111)   66,936 
Other revenue   261,846    830,263    (568,417)
TOTAL REVENUES   5,394,111    4,250,590    1,143,521 
                
EXPENSES               
Compensation, payroll taxes and benefits   2,718,784    3,123,630    (404,846)
Data processing and clearing costs   1,897,046    584,250    1,312,796 
Regulatory, professional fees and related expenses   1,302,136    250,573    1,051,563 
Stock compensation expense   606,740    155,411    451,329 
Communications   195,547    218,869    (23,322)
Occupancy and equipment   103,595    36,751    66,844 
Transfer fees   18,415    48,160    (29,745)
Bank charges   60,570    58,718    1,852 
Bad debt   62,328    40    62,288 
Intangible assets amortization   355,795    355,795    — 
Other   592,717    295,631    297,086 
TOTAL EXPENSES   7,913,673    5,127,828    2,785,845 
                
LOSS FROM OPERATIONS   (2,519,562)   (877,238)   (1,642,324)
                
OTHER INCOME/(EXPENSE)               
Interest income   496,135    486,357    9,778 
Change in fair value of warrant liability derivative   344,380    (61,531)   405,911 
Change in fair value, convertible note derivative   —    (52,873)   52,873 
Change in fair value, long-term and short-term note derivative   —    103,185    (103,185)
Change in fair value of secured convertible note   665,192    —    665,192 
Change in fair value of Merger financing   —    63,696    (63,696)
Change in fair value of earnout liability   249,000    (116,000)   365,000 
Change in fair value of subscription agreement   —    1,798,624    (1,798,624)
Change in fair value of debenture   (109,721)   (837,888)   728,167 
Change in fair value of Tau agreement   —    334,549    (334,549)
Interest expense   (401,713)   (1,434,210)   1,032,497 
TOTAL OTHER INCOME/(EXPENSE)   1,243,273    283,909    959,364 
                
Income before provision for income taxes   (1,276,289)   (593,329)   (682,960)
Benefit (provision) for income taxes   223,318   153,035    70,283
Net income (loss)  $(1,052,971)  $(440,294)   (612,677)

 

39
Table of Contents

 

Total revenues increased by $1,143,521, or 27%, to $5,394,111 for the three months ended September 30, 2026, compared to $4,250,590 for the three months ended September 30, 2025.

 

AtlasClearing is a self-clearing correspondent securities broker-dealer registered with the SEC and a member in good standing of FINRA. AtlasClearing is engaged principally in over-the-counter (“OTC”) microcap securities transactions (defined as companies with market capitalizations under $250 million, including penny stocks trading under $5.00 per share with market capitalizations under $50 million), as well as exchange-traded securities. It derives its revenue from liquidations of restricted and control microcap securities; clearing transactions on behalf of introducing broker-dealers on a fully disclosed basis; and trading in equity securities for its own account. Secondary revenues stem from fully paid stock lending, stock locates, and margin accounts. Historical activities also include underwritten at-the-market offerings, private placements, mutual fund sales, and ancillary financial services.

 

The net revenue growth was primarily driven by $2,997,205 generated from stock locate fees during the three months ended September 30, 2026. This increase was partially offset by decreases in clearing fees (down $612,563, or 86%), commissions (down $597,955, or 26%), other revenue (down $568,417, or 68%), and vetting fees (down $141,685, or 38%).     

 

Operating Expenses

 

Total operating expenses increased by $2,785,845, or 54%, to $7,913,673 for the three months ended September 30, 2026, compared to $5,127,828 for the three months ended September 30, 2025. Primary drivers of period-over-period variations include:     

 

Compensation, Payroll Taxes, and Benefits: Decreased by $404,846, or 13%, to $2,718,784 for the three months ended September 30, 2026, compared to $3,123,630 for the prior three month period. Variable compensation continues to correlate with line-item volume shifts across operations.     

 

Data Processing and Clearing Costs: Increased by $1,312,796, or 225%, to $1,897,046 for the three months ended September 30, 2026, from $584,250 for the prior three month period. Primary drivers for the increase is due to cost associated to the new stock locate revenue stream.     

 

Regulatory, Professional Fees, and Related Expenses: Increased by $1,051,563, or 420%, to $1,302,136 for the three months ended September 30, 2026, compared to $250,573 for the three months ended September 30, 2025, driven by higher legal and professional advisory requirements in the current period as a result of the planned transaction with Commercial Bancorp and Ark.     

 

Stock-Based Compensation: Increased by $451,329, or 290%, to $606,740 for the three months ended September 30, 2026, compared to $155,411 in the prior three month period. This reflects the continued pro-rata amortization over the requisite service periods of stock-based compensation granted under executive officer employment agreements and additional stock options grants in the quarter.

   

Occupancy and Equipment: Increased by $66,844, or 182%, to $103,595 for the three months ended September 30, 2026, from $36,751 for the prior three months period.     

 

Other expenses: Increased by $297,086, or 100%, to $592,717 for the three months ended September 30, 2026, from $295,631 for the prior three-month period.  The increase was primarily driven by a true-up entry recorded as of September 30, 2026. The Company routinely adjusts its monthly balances to match FIS reports as of the final day of each reporting period. Management believes the period-over-period variance is largely attributable to timing differences between the balance sheet and the underlying adjusted accounts.

 

Other Income (Expense)

 

Total other income increased by $959,364, or 338%, to $1,243,273 for the three months ended September 30, 2026, compared to $283,909 for the three months ended September 30, 2025.

   

The primary variance in other income was driven by fair value adjustments on financial instruments and derivative liabilities:   

 

During the three months ended September 30, 2026, the Company recognized fair value gains on the Secured Convertible note ($665,192), Warrant Liability ($344,380), and Earnout Liability ($249,000), offset by a fair value loss on the Debenture derivative of $109,721.     

 

In contrast, the prior period ending September 30, 2025, included a $1,798,624 fair value gain on the Subscription Agreement, offset by fair value losses on Debentures ($837,888) and Earnout Liability ($116,000). In addition, remaining seller note balances were converted into shares during the prior year, resulting in a fair value adjustment of $103,185.     

 

Interest Expense: Decreased by $1,032,497, or 72%, to $401,713 for the three months ended September 30, 2026, from $1,434,210 for the three months ended September 30, 2025, reflecting lower outstanding principal balances on debt instruments during the current period.     

 

Income Taxes

 

Income tax benefit was $223,318 for the three months ended September 30, 2026, compared to an income tax benefit of $153,035 for the three months ended September 30, 2025. The increase in tax benefit of $70,283 was primarily attributable to changes in deferred tax liabilities and assets and valuation allowance assessments.     

 

Net Loss

 

As a result of the operational and non-operating factors outlined above, net loss increased by $612,677 to $1,052,971 for the three months ended September 30, 2026, compared to a net loss of $440,294 for the three months ended September 30, 2025.

 

40
Table of Contents

 

Liquidity and Capital Resources

 

Net cash used in operating activities was $3,867,059 for the three months ended September 30, 2026, compared to net cash used in operating activities of $2,500,236 for the three months ended September 30, 2025. The increase in cash used in operations was primarily driven by the following factors:

 

●Net Loss and Non-Cash Items: Our operating cash flows for the current period were impacted by our net loss of $1,052,971, which was offset by significant non-cash adjustments including net fair value gains on financial instruments and derivative liabilities (such as the Secured Convertible Note (Funicular) fair value gain of $665,192, Warrant liability gain of $344,380, and Earnout liability gain of $249,000, offset by Debenture losses of $109,721), stock-based compensation expense of $606,740, amortization of intangibles of $355,795, non-cash interest expense of $344,825, and bad debt expense of $62,328.
   
●Working Capital Fluctuations: Changes in operating assets and liabilities used net cash during the period, primarily resulting from an increase in receivables from customers of $5,560,889, decreases in accounts payable and accrued expenses of $660,234, and decreases in commissions and payroll taxes payable of $482,449. These outflows were partially offset by positive cash impacts from a decrease in receivables from brokers and dealers of $2,467,410 and an increase in payables to customers of $1,482,024.

 

Investing Activities

 

Net cash used in investing activities was $0 for the three months ended September 30, 2026, compared to $65,000 for the three months ended September 30, 2025. The prior-period cash outflow was entirely attributable to cash paid for purchase of Pacsquare.

 

Financing Activities

 

Net cash used in financing activities was $137,260 for the three months ended September 30, 2026, compared to net cash provided by financing activities of $5,140,445 for the three months ended September 30, 2025.

 

●Current Period: Cash outflows during the three months ended September 30, 2026, consisted exclusively of promissory note repayments totaling $137,260.
   
●Comparative Period: In contrast, cash inflows during the three months ended September 30, 2025, were driven by capital raises, including $4,700,000 in net proceeds from the Securities Agreement, $490,000 in proceeds from debentures, and $200,000 in third-party advances, offset by $249,555 in promissory note repayments.

 

Going Concern Consideration

 

As of September 30, 2026, the Company had unrestricted cash and cash equivalents of $9.4 million and has experienced recurring operating losses and negative cash flows from operations since inception. During the three months ended September 30, 2026, and in the period immediately following the balance sheet date, the Company incurred significant cash outflows, including operating cash expenditures, a $2.5 million cash payment in October 2026 related to the Ark acquisition (see Note 15). In addition, additional cash commitments are expected for $2.44 million due at the Ark closing, and the Company has a $2.5 million seller note maturing in January 2027.

 

Management evaluated the Company’s liquidity position and continuous operational plans in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Subtopic 205-40, Presentation of Financial Statements – Going Concern. Management’s base cash flow forecast for the twelve months following the issuance date of these condensed consolidated financial statements indicates that projected operating cash flows and existing cash balances on hand may not be sufficient to satisfy all anticipated obligations as they become due.

 

However, management has evaluated probable and executable mitigation plans. Specifically, the Company has accessible capital resources that can be drawn down or completed to fully fund any potential cash flow deficits. While management does not anticipate requiring capital beyond baseline operational expectations, these funding mechanisms are available, and management believes them to be sufficient to absorb any liquidity shortfalls during the assessment period.

 

Based on the available capital resources and management’s operational and financial mitigation plans, management expects to have sufficient liquidity to satisfy its obligations as they become due for at least twelve months following the date these condensed consolidated financial statements are issued. Accordingly, management concluded that there is no substantial doubt about the Company’s ability to continue as a going concern.

 

Off-Balance Sheet Arrangements

 

The Company has no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of September 30, 2026.

 

41
Table of Contents

 

Contractual Obligations

 

The Company holds several long-term debt obligations with outside vendors and investors, with loans maturing between 2026 and 2030 (see Notes 8 and 9 in the accompanying condensed consolidated financial statements). Additionally, the Company leases office space under several operating leases. The Company has no capital lease obligations. Further, there are no other outstanding long-term liabilities contractually obligated by the Company.

  

Critical Accounting Policies

 

The preparation of consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates.

 

Derivative Liabilities

 

We account for derivative instruments as either equity-classified or liability-classified instruments based on an assessment of the derivative instruments’ specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) ASC 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the derivative instruments are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the derivative instruments meet all of the requirements for equity classification under ASC 815, including whether the derivative instruments are indexed to our own Common Stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of issuance and as of each subsequent quarterly period end date while financial instruments are outstanding.

 

For issued or modified derivatives that meet all of the criteria for equity classification, the derivatives are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified derivatives that do not meet all the criteria for equity classification, the derivatives are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the derivatives are recognized as a non-cash gain or loss on the statements of operations.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

Not required for smaller reporting companies.

 

Item 4. Controls and Procedures

 

Disclosure Controls and Procedures

 

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that such information is accumulated and communicated to the company’s management, including its chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure.

 

As of September 30, 2026, an evaluation of the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) was carried out by our management, with the participation of our Executive Chairman (our principal executive officer) and Chief Financial Officer (CFO). Based upon that evaluation, the Executive Chairman and CFO have concluded that as of the end of that fiscal quarter, our disclosure controls and procedures were effective as of September 30, 2026.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting during the quarter ended September 30, 2026.

 

42
Table of Contents

 

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings

 

We are, from time to time, party to various legal proceedings arising in the ordinary course of business, including as disclosed in Note 10 to the accompanying condensed consolidated financial statements. We are currently not party to any litigation , the outcome of which, if determined adversely to us, would individually or in the aggregate be reasonably expected to have a material and adverse effect on our business, financial position or results of operations.

 

Item 1A. Risk Factors

 

Factors that could cause our actual results to differ materially from those in this report include the risk factors described in our Annual Report. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in our Annual Report, other than the following amended and restated or new risk factors:

 

We have been suspended from the NYSE American and are currently not in compliance with the continued listing standards of the NYSE American. Our failure to resume compliance with the continued listing standards or make continued progress toward compliance consistent with a plan of compliance that we submitted to NYSE Regulation may result in the delisting of our common stock.

 

On November 10, 2026, the Company received notice from NYSE Regulation of the NYSE that it had suspended trading of the Company’s Common Stock on the NYSE American and determined to commence proceedings to delist the Company’s common stock from the NYSE American as a result of its determination that the Company is no longer suitable for listing pursuant to Section 1003(f)(v) of the NYSE American Company Guide due to the low selling price of the Company’s common stock. Trading of the Company’s common stock on the NYSE American was suspended on November 10, 2026 and began trading on the OTC Pink Limited Market on November 11, 2026. The Company has a right to a review of NYSE Regulation’s determination to delist the Company’s common stock by the Listings Qualifications Panel of the Committee for Review of the Board of Directors of the Exchange, and the Company intends to request such a review; however, there can be no assurance that any such appeal will be successful.

 

Because our common stock has been suspended from the NYSE American and is now listed on the Pink Limited Market of the OTC Markets Group, we could face significant material adverse consequences, including:

 

●a limited availability of market quotations for our securities;
   
●reduced liquidity with respect to our securities;
   
●a determination that our shares of Common Stock are “penny stock” which will require brokers trading in our shares of Common Stock to adhere to more stringent rules, possibly resulting in a reduced level of trading activity in the secondary trading market for our shares of Common Stock; and
   
●a decreased ability to issue additional securities or obtain additional financing in the future.

 

Such a delisting may also have a negative effect on the price of our Common Stock and may impair our investors’ ability to sell or purchase our Common Stock when investors wish to do so.

 

The National Securities Markets Improvement Act of 1996, which is a federal statute, prevents or preempts the states from regulating the sale of certain securities, which are referred to as “covered securities.” Shares of our Common Stock were considered to be covered securities because they were listed on the NYSE American. If our Common Stock is not listed on the NYSE American, it would not be deemed covered securities and we will be subject to regulation in each state in which we offer our securities.

 

We may not be able to successfully consummate the acquisitions of Ark or an institutional digital asset business.

 

On October 14, 2026, we entered into the Acquisition Agreement to acquire Ark and its wholly-owned subsidiary, Dawson James Securities, Inc., and on July 22, 2026, we announced that we had entered into a letter of intent to acquire an institutional digital asset business. The Acquisition Agreement contains a number of conditions to Closing, including the receipt of all required regulatory approvals (including the consent of FINRA) and the Company’s stockholders having approved the issuance of the shares of Common Stock pursuant to the Acquisition Agreement, if such stockholder approval is required pursuant to the listing rules of the NYSE American. There can be no assurance that the transactions contemplated by the Acquisition Agreement will be completed on a timely basis, or at all.

 

In addition, the letter of intent for the institutional digital asset business is non-binding, except for certain provisions including exclusivity and confidentiality. The completion of a definitive agreement to acquire the institutional digital asset business remains subject to a number of factors, including due diligence satisfactory to us and board approvals by both companies. Although the letter of intent provides that certain provisions are binding on the parties, it does not obligate the parties to consummate the proposed transaction. If a definitive agreement is entered into, the closing of the transaction will be subject to various closing conditions, including regulatory approval. There can be no assurance that any definitive agreement for the institutional digital asset business will be entered into or that the proposed transaction (or either of them) will be consummated on the terms contemplated by the letter of intent, or at all.

 

Our pending acquisitions of Commercial Bancorp, Ark or any other potential acquisition we may pursue involve a number of risks, the occurrence of which could materially adversely affect our business, financial condition and operating results.

 

Our pending acquisitions of Commercial Bancorp and Ark involve, and any other acquisition we may pursue may involve, a number of risks, including the following:

 

●delays in completing the acquisition within the expected time period and the risk that the acquisition may not be completed at all;
  
●the occurrence of any fact, event, change, development or circumstance that could give rise to the termination of the acquisition agreement;
  
●the failure to satisfy any of the conditions to the consummation of any such acquisition;

 

43
Table of Contents

 

●significant dilution to our existing stockholders as a result of the issuance of shares of Common Stock and/or other securities as consideration;
  
●diversion of management’s attention to complete the acquisition;
  
●the announcement and/or consummation of the acquisition disrupting the Company’s current plans or operations;
  
●potential litigation relating to the acquisition, including any resulting costs, delays or diversion of management’s attention;
  
●significant transactions costs and expenses associated with the acquisition, whether or not it is completed;
  
●the failure to recognize the anticipated benefits of the acquisition, which may be affected by, among other things, the potential loss of customers and/or employees of the acquired business, competition, and/or the ability of the Company to grow and manage growth profitably; and
  
●the risk that costs savings and other anticipated synergies from the acquisition may not be realized when expected, or at all.

 

The occurrence of any of the above risks could materially adversely affect our business, financial condition and operating results.

 

Commercial Bancorp, Ark or any other business we may acquire may have liabilities that are not known to AtlasClear and the indemnities negotiated in the applicable acquisition agreement may not offer adequate protection.

 

AtlasClear expects to assume certain liabilities of Commercial Bancorp, Ark and the institutional digital asset business if any such transaction is consummated. There may be liabilities that AtlasClear failed or was unable to discover in the course of performing due diligence investigations into these companies. AtlasClear may also have not correctly assessed the significance of certain liabilities identified in the course of its due diligence. Any such liabilities, individually or in the aggregate, could have a material adverse effect on the combined company’s business, financial condition and results of operations. As we integrate Commercial Bancorp, Ark or any other acquired business into our operations, we may learn additional information about the acquired business, such as unknown or contingent liabilities and issues relating to compliance with applicable laws, that could potentially have a materially adverse effect on our business, financial condition and results of operations.

 

Item 2. Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities. 

 

None.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

Item 5. Other Information

 

During the three months ended September 30, 2026, none of the Company’s directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K.

 

Item 6. Exhibits

 

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report.

 

Exhibit No.   Description
3.1   Amended and Restated Certificate of Incorporation of AtlasClear Holdings, Inc. (formerly Calculator New Pubco, Inc.) (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K (File No. 001-41956), filed with the SEC on February 15, 2024).
3.2   Certificate of Amendment to Amended and Restated Certificate of Incorporation of AtlasClear Holdings, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K (File No. 001-41956), filed with the SEC on January 8, 2025).
3.3   Certificate of Amendment to Amended and Restated Certificate of Incorporation of AtlasClear Holdings, Inc. (incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K (File No. 001-41956), filed with the SEC on January 8, 2025).
3.4   Amended and Restated By-Laws of AtlasClear Holdings, Inc. (incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K (File No. 001-41956), filed with the SEC on February 15, 2024).
3.5   Amendment to the Amended and Restated By-Laws of the Company (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K (File No. 001-41956), filed with the SEC on December 27, 2024).
10.1   Amendment No. 1 to Debenture Agreement between the Registrant and Sixth Borough Capital Fund, LP, dated September 11, 2026 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (File No. 001-41956), filed with the SEC on September 15, 2026).
31.1*   Certification of the Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a).
31.2*   Certification of the Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a).
32.1**   Certification of the Chief Executive Officer and the Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350.
101.INS*   XBRL Instance Document
101.SCH*   XBRL Taxonomy Extension Schema Document
101.CAL*   XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*   XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*   XBRL Taxonomy Extension Label Linkbase Document
101.PRE*   XBRL Taxonomy Extension Presentation Linkbase Document
104*   Cover Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

 

 

* Filed herewith.

** Furnished herewith.

# Indicates management contract or compensatory plan, contract or arrangement.

 

44
Table of Contents

 

SIGNATURES

 

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  ATLASCLEAR HOLDINGS, INC.
     
Date: November 13, 2026 By: /s/ John Schaible
  Name: John Schaible
  Title: Executive Chairman
    (Principal Executive Officer)
     
Date: November 13, 2026 By: /s/ Sandip Patel
  Name: Sandip Patel
  Title: General Counsel and Chief Financial Officer
    (Principal Financial Officer)

 

45

 

Keep reading